ABBV


Line plots across dimensions of each concept
Line plots across concepts
Tables

Table of contents


us-gaap:StatementEquityComponents
us-gaap:SharesOutstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareDiluted

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

us-gaap:CostOfGoodsAndServicesSold
us-gaap:DerivativeInstrumentRisk, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:CostsAndExpenses

us-gaap:GrossProfit

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

us-gaap:IncomeTaxExpenseBenefit
us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:InterestExpense

us-gaap:InterestIncomeExpenseNonoperatingNet
us-gaap:DerivativeInstrumentRisk, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:NetIncomeLoss
us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
us-gaap:StatementEquityComponents

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted

us-gaap:OperatingIncomeLoss

us-gaap:OtherComprehensiveIncomeLossNetOfTax
us-gaap:StatementEquityComponents

us-gaap:OtherNonoperatingIncomeExpense

us-gaap:ProfitLoss

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
abbv:KeyProductPortfolio, us-gaap:ProductOrService
abbv:KeyProductPortfolio, us-gaap:ProductOrService, us-gaap:StatementGeographical
us-gaap:ProductOrService

us-gaap:Revenues

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:Assets

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:ShortTermInvestments

us-gaap:AccountsReceivableNetCurrent
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

us-gaap:InventoryNet

us-gaap:NoncurrentAssets
us-gaap:StatementGeographical

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:AmortizationOfIntangibleAssets
us-gaap:BusinessAcquisition

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:LongTermInvestments

us-gaap:Goodwill
us-gaap:BusinessAcquisition

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:BalanceSheetLocation
us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OtherAssetsNoncurrent
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByMeasurementFrequency

us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

us-gaap:AccountsPayableCurrent

us-gaap:DividendsPayableCurrent

us-gaap:LiabilitiesCurrent
us-gaap:BalanceSheetLocation
us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:LongTermDebt
us-gaap:DebtInstrument
us-gaap:DebtInstrument, us-gaap:LongtermDebtType

us-gaap:DebtAndCapitalLeaseObligations
us-gaap:DebtInstrument, us-gaap:LongtermDebtType

us-gaap:LongTermDebtAndCapitalLeaseObligations

us-gaap:DeferredIncomeTaxLiabilitiesNet

us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
us-gaap:RetirementPlanType

us-gaap:MinorityInterest

us-gaap:OtherLiabilitiesNoncurrent
us-gaap:BalanceSheetLocation
us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

us-gaap:OperatingLeaseLiability

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:StockholdersEquity

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapitalCommonStock

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:TreasuryStockValue

us-gaap:MinorityInterest

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:DeferredIncomeTaxExpenseBenefit

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInInventories

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss
us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
us-gaap:StatementEquityComponents

us-gaap:ProfitLoss

us-gaap:ShareBasedCompensation

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:ProceedsFromIssuanceOfLongTermDebt

us-gaap:PaymentsOfDividends

us-gaap:PaymentsForRepurchaseOfCommonStock

us-gaap:EffectiveIncomeTaxRateContinuingOperations
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

us-gaap:DeferredTaxLiabilities

us-gaap:DeferredTaxAssetsNet

us-gaap:UnrecognizedTaxBenefits

us-gaap:DeferredTaxAssetsValuationAllowance
us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:TypeOfArrangement
abbv:AdditionalContributionToCollaboration
us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:TypeOfArrangement
abbv:AdditionalContributionToCollaborationByPartner
us-gaap:BusinessAcquisition
abbv:AmortizationofInventoryFairValueStepup
us-gaap:BusinessAcquisition
abbv:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNet
us-gaap:BusinessAcquisition
abbv:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsDeferredIncomeTaxLiabilities
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
abbv:CollaborativeArrangementsPercentageOfShareOfDevelopmentCosts
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
abbv:CollaborativeArrangementsPercentageOfShareOfDevelopmentCostsResponsibleByThirdParty
us-gaap:CounterpartyName, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
abbv:CostofGoodsAndServicesSoldFromCollaborativeArrangements
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
us-gaap:RetirementPlanType
abbv:DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit

abbv:EffectiveIncomeTaxRateReconciliationTaxLawChangesAmount
us-gaap:IncomeStatementLocation, us-gaap:RestructuringPlan
abbv:EffectonFutureEarningsPercent

abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax

abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeTax
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
abbv:OtherExpensesFromCollaborativeArrangements
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
abbv:ResearchAndDevelopmentExpenseFromCollaborativeArrangements
us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement
abbv:ResearchandDevelopmentAssetAcquiredOtherthanThroughBusinessCombinationWrittenoffMilestonePayment
us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement
abbv:ResearchandDevelopmentAssetAcquiredOtherthanThroughBusinessCombinationWrittenoffUpfrontPayment
us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan
abbv:RestructuringReserveCashSettledRestructuringGainsLosses
us-gaap:RestructuringPlan
us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan
abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments
us-gaap:RestructuringPlan
us-gaap:CounterpartyName, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
abbv:SellingGeneralAndAdministrativeExpenseFromCollaborativeArrangements

abbv:UpfrontCostsRelatedToCollaborations

us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
us-gaap:BusinessAcquisition
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
us-gaap:BusinessAcquisition
us-gaap:BusinessAcquisitionsProFormaRevenue
us-gaap:BusinessAcquisition, us-gaap:IncomeStatementLocation
us-gaap:BusinessCombinationAcquisitionRelatedCosts
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationConsiderationTransferred1
us-gaap:StatementScenario, us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles

us-gaap:CommonStockDividendsPerShareDeclared
us-gaap:SubsequentEventType
us-gaap:ConcentrationRiskByBenchmark, us-gaap:ConcentrationRiskByType
us-gaap:ConcentrationRiskPercentage1
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanInterestCost
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanServiceCost

us-gaap:Depreciation
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation
us-gaap:DerivativeGainLossOnDerivativeNet
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:DividendsCommonStockCash
us-gaap:StatementEquityComponents

us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
us-gaap:BusinessAcquisition

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax

us-gaap:GoodwillForeignCurrencyTranslationGainLoss

us-gaap:GoodwillPurchaseAccountingAdjustments
us-gaap:BusinessAcquisition

us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:IncomeStatementLocation
us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1

us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

us-gaap:InvestmentIncomeInterest

us-gaap:MinorityInterestPeriodIncreaseDecrease
us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
us-gaap:StatementEquityComponents
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax

us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
us-gaap:HedgingDesignation, us-gaap:LongtermDebtType

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

us-gaap:OtherNoncashIncomeExpense

us-gaap:OtherOperatingIncomeExpenseNet

us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic

us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted

us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities

us-gaap:PaymentOfFinancingAndStockIssuanceCosts

us-gaap:PaymentsForProceedsFromOtherInvestingActivities
us-gaap:BusinessAcquisition
us-gaap:PaymentsToAcquireBusinessesGross
us-gaap:BusinessAcquisition, us-gaap:SubsequentEventType

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired

us-gaap:PaymentsToAcquireMarketableSecurities

us-gaap:PaymentsToAcquireOtherInvestments

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:SubsequentEventType

us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments

us-gaap:ProceedsFromStockOptionsExercised
us-gaap:StatementEquityComponents
us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
us-gaap:StatementEquityComponents
us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
us-gaap:StatementEquityComponents
us-gaap:ReclassificationFromAociCurrentPeriodTax

us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
us-gaap:DebtInstrument, us-gaap:LongtermDebtType

us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement
us-gaap:IncomeStatementLocation, us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan
us-gaap:RestructuringAndRelatedCostIncurredCost
us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan
us-gaap:RestructuringPlan
abbv:KeyProductPortfolio, us-gaap:ProductOrService, us-gaap:StatementGeographical
us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
us-gaap:CounterpartyName, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesAcquisitions
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation

us-gaap:StockIssuedDuringPeriodValueAcquisitions
us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
us-gaap:StatementEquityComponents
us-gaap:ShareRepurchaseProgram
us-gaap:TreasuryStockSharesAcquired
us-gaap:StatementEquityComponents

us-gaap:TreasuryStockValueAcquiredCostMethod
us-gaap:ShareRepurchaseProgram
us-gaap:StatementEquityComponents

abbv:AccruedSalesRebates
us-gaap:BusinessAcquisition
abbv:AdditionalContributionToAcquireInProcessResearchAndDevelopmentCollaborations
us-gaap:CounterpartyName
abbv:ConsiderationReceivableFromCounterpartyForReacquiredRights

abbv:DeferredTaxAssetsChargebacksAndRebates

abbv:DeferredTaxAssetsOperatingLossAndOtherTaxCreditCarryforwards

abbv:LeaseLiability

abbv:LeaseLiabilityPaymentsDue

abbv:LeaseLiabilityPaymentsDueNextRollingTwelveMonths

abbv:LeaseLiabilityPaymentsDueYearFive

abbv:LeaseLiabilityPaymentsDueYearFour

abbv:LeaseLiabilityPaymentsDueYearThree

abbv:LeaseLiabilityPaymentsDueYearTwo

abbv:LeaseLiabilityPaymentsDueafterYearFive

abbv:LeaseLiabilityUndiscountedExcessAmount

abbv:LeaseRightofUseAsset
us-gaap:FairValueByFairValueHierarchyLevel
abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:FairValueByMeasurementBasis

abbv:LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedDiscounts

abbv:LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedFinancingCosts
us-gaap:FairValueByFairValueHierarchyLevel
abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:FairValueByMeasurementBasis

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueHedgesNet

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueHedgesUnamortizedBondPremiumsAndDiscountsDeferredFinancingCostsAndFinanceLeaseObligations
us-gaap:DebtInstrument
abbv:LongTermDebtAndCapitalLeaseObligationsGross
us-gaap:DebtInstrument, us-gaap:LongtermDebtType

abbv:LongTermDebtAndFinanceLeaseObligationsDebtInstrumentUnamortizedPremiums
us-gaap:LitigationCase
abbv:NumberOfCasesConsolidatedForPreTrialPurposes
us-gaap:CounterpartyName, us-gaap:Range, us-gaap:StatementScenario, us-gaap:TypeOfArrangement
abbv:PotentialPaymentsUnderAgreementCertainMilestones
us-gaap:CounterpartyName, us-gaap:Range, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:ReimbursementReceivableForUnrecognizedTaxBenefitAndRelatedInterestAndPenalties
us-gaap:AwardType
abbv:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageGrantDateFairValue

abbv:UnrecognizedTaxBenefitsLiabilities

us-gaap:AccruedIncomeTaxesNoncurrent

us-gaap:AccruedRoyaltiesCurrent
us-gaap:RetirementPlanType
us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:AssetsFairValueDisclosure
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByMeasurementFrequency
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationContingentConsiderationLiability
us-gaap:BusinessAcquisition, us-gaap:SubsequentEventType
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency
us-gaap:MeasurementInputType
us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
us-gaap:Range, us-gaap:MeasurementInputType

us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:CashAndCashEquivalentsFairValueDisclosure
us-gaap:FairValueByMeasurementFrequency

us-gaap:CommonStockValueOutstanding
us-gaap:DebtInstrument
us-gaap:DebtInstrumentUnamortizedPremium

us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible

us-gaap:DeferredIncomeTaxLiabilities

us-gaap:DeferredTaxAssetsDeferredIncome

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsOther

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals

us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

us-gaap:DeferredTaxLiabilitiesInvestments

us-gaap:DeferredTaxLiabilitiesOther

us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
us-gaap:RetirementPlanSponsorLocation
us-gaap:DefinedBenefitPlanBenefitObligation
us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
us-gaap:DefinedBenefitPlanByPlanAssetCategories, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanFundedStatusOfPlan

us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets

us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation

us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets

us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
us-gaap:DefinedBenefitPlanByPlanAssetCategories, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage

us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1

us-gaap:DerivativeFairValueOfDerivativeAsset
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementFrequency

us-gaap:DerivativeFairValueOfDerivativeLiability
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementFrequency
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:DerivativeNotionalAmount
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:EmployeeRelatedLiabilitiesCurrent
us-gaap:AwardType
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
us-gaap:AwardType
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

us-gaap:FinanceLeaseLiability
us-gaap:BalanceSheetLocation
us-gaap:FinanceLeaseLiabilityCurrent
us-gaap:BalanceSheetLocation
us-gaap:FinanceLeaseLiabilityNoncurrent

us-gaap:FinanceLeaseLiabilityPaymentsDue

us-gaap:FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths

us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour

us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree

us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo

us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
us-gaap:BalanceSheetLocation
us-gaap:FinanceLeaseRightOfUseAsset

us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

us-gaap:FiniteLivedIntangibleAssetsGross
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:IncomeStatementLocation
us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months

us-gaap:IntangibleAssetsGrossExcludingGoodwill
us-gaap:IncomeStatementLocation
us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:InterestRateDerivativeAssetsAtFairValue
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
us-gaap:FairValueByMeasurementFrequency

us-gaap:InventoryFinishedGoodsNetOfReserves

us-gaap:InventoryRawMaterialsNetOfReserves

us-gaap:InventoryWorkInProcessNetOfReserves
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
us-gaap:InvestmentsFairValueDisclosure
us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:LiabilitiesFairValueDisclosure
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementBasis
us-gaap:FairValueByMeasurementFrequency

us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
us-gaap:LongtermDebtWeightedAverageInterestRate

us-gaap:LossContingencyAccrualAtCarryingValue
us-gaap:LitigationCase
us-gaap:LossContingencyPendingClaimsNumber
us-gaap:LossContingenciesByNatureOfContingency

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
us-gaap:IncomeTaxAuthority
us-gaap:OperatingLossCarryforwards

us-gaap:OtherAccruedLiabilitiesNoncurrent
us-gaap:RetirementPlanType
us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities

us-gaap:PrepaidExpenseAndOtherAssets
us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan
us-gaap:RestructuringReserve
us-gaap:RestructuringPlan
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
us-gaap:AwardType
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

us-gaap:ShortTermBorrowings
us-gaap:ShortTermDebtType
us-gaap:ShortTermDebtWeightedAverageInterestRate
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:ShorttermDebtFairValue
us-gaap:FairValueByMeasurementBasis

us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
us-gaap:ShareRepurchaseProgram
us-gaap:IncomeTaxAuthority
us-gaap:TaxCreditCarryforwardAmount

us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

Plots across concepts


IncomeStatement
Other Comprehensive Income Loss Net Of Tax
Expenses
Other Nonoperating Income Expense
Balance Sheet
Short Term Investments
Assets
Inventory Net
Current Assets
Inventory Net
NonCurrent Assets
Long Term Investments
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Short Term Borrowings
Noncurrent Liabilities
Minority Interest
Stockholders Equity
Accumulated Other Comprehensive Income Loss Net Of Tax
Per Share
Earnings Per Share Diluted
CashFlow
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInOperatingActivities
Increase Decrease In Prepaid Deferred Expense And Other Assets
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInFinancingActivities
Net Cash Provided By Used In Financing Activities
Shares
Weighted Average Number Of Shares Outstanding Basic
DividendsAndRepurchase
Payments For Repurchase Of Common Stock
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Four
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization
InventoryNet
Inventory Raw Materials Net Of Reserves
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Tables

  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
 us-gaap:SharesOutstanding us-gaap:StatementEquityComponents us-gaap:CommonStock█████▁▁▁▁▁▁▂▂▄▄1767.01766.01765.01765.01764.01477.01479.01479.01478.01478.01479.01504.01514.01587.01592.0NANANA1593.0NANANA1610.0NANANA1591.0NANANA1587.0NANANANANANANA
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding █▁1776.01775.0NA1774.01647.01484.0NA1483.01484.01483.0NA1515.01572.01596.0NA1603.01600.01603.0NA1640.01632.01625.0NA1664.01633.01608.0NA1610.01608.01609.0NA1605.01609.01605.0NA1577.01577.01577.0
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic ▄▄1769.01769.0NA1769.01647.01481.0NA1481.01480.01480.0NA1511.01568.01591.0NA1597.01595.01597.0NA1632.01624.01616.0NA1652.01620.01595.0NA1595.01594.01595.0NA1590.01589.01588.0NA1577.01577.01577.0
us-gaap:EarningsPerShareBasic ▅█▄▆▃██▆▅▇▁█▆▇▄▆▆▆▆▆▆▅▆▅▅▅▃▄▅▅▅▅▅▅▆▆▅▅0.422.00.011.3-0.462.021.881.270.491.65-1.231.811.261.740.031.021.21.070.860.970.990.830.930.750.840.64-0.510.320.690.610.70.60.670.610.981.010.80.56
us-gaap:EarningsPerShareDiluted ▅█▄▆▃██▆▅▇▁█▆▇▄▆▆▆▅▆▆▅▆▅▅▅▃▄▅▅▅▅▅▅▆▆▅▅0.421.990.011.29-0.462.021.881.260.491.65-1.231.811.261.740.031.011.191.060.850.970.980.830.920.740.830.63-0.510.310.680.610.70.60.660.60.981.010.80.56
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
 TTM Greenblatt ROC _ _██▇▇▄▇█▆▇▇▁▇▆▆▅▆▆▆▆▆▆▆▆▅▅▅▃▄▅▅▅▅▅▅▅4441.04103.03753.03255.0752.03603.03956.02617.03400.03010.0-2441.03159.02762.02903.01794.02705.02674.02419.02358.02361.02387.02278.02113.01885.01852.01687.0-415.0960.01515.01351.01535.01371.01453.01305.01821.0NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:AllocatedShareBasedCompensationExpense ▅█▄▅▇▇▂▂▃▆▂▂▃▆▂▂▂▄▂▁▄▄▂▂▂▄▁▁▂▃▁▁▁▃▁▁▁▃159.0269.0136.0162.0236.0219.079.075.087.0189.070.075.085.0191.077.071.076.0141.075.047.0137.0138.053.055.055.0119.043.044.049.0106.037.041.046.087.031.030.035.091.0
us-gaap:ComprehensiveIncomeNetOfTax ▅█▄▇▃▇▆▆▅▇▁▇▆▇▃▆▆▆▅▆▆▆▅▅▅▄▁▄▅▅▆▅▅▅▆▆▅▅958.03375.0178.02484.0-476.02909.01733.01847.0766.02420.0-1747.02827.01974.02880.0-62.01566.01909.01755.01145.01648.01643.01492.01455.01114.01459.0586.0-1928.013.01104.0996.01647.01152.01136.0763.01530.01866.0747.01103.0
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest ▆▄▄█▁3.02.02.05.0-1.0NANANA0.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest ▄█▂▆▁▇▅▅▃961.03377.0180.02489.0-477.02909.01733.01847.0766.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:CostOfGoodsAndServicesSold ▇▆▇█▅▂▂▂▁▁▂▁▂▂▂▁4523.04213.04684.05050.03711.01942.02006.01920.01819.01694.02022.01835.01934.01927.02281.01616.0NANANANANANANANANANANANANANANANANANANANANANA
us-gaap:CostsAndExpenses ▇▆▇▇▇▃▃▄▃▃█▃▃▃▄▂▂▂▂▂▂▂▂▂▂▁▄▂▁▁▂▁▁▁▁▁▁▁9518.08907.010105.09647.09673.05016.04748.05862.04855.04818.010746.05077.05516.05031.05945.04290.04270.04119.04438.04071.04065.03680.04287.04059.03623.03353.05867.04059.03411.03212.03576.03287.03239.03024.03385.02912.03071.03195.0
us-gaap:GrossProfit NANA9174.0NANANA6698.06559.06436.06134.06283.06401.06344.06007.05459.05379.05416.04922.05241.04928.05047.04589.04925.04777.04559.04098.04333.03925.03813.03463.03829.03566.03638.03176.03941.03494.03420.03017.0
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments ▅█▂▆▃▇▇▆▅▇▁▇▆▇▅▆▆▆▆▆▆▆▆▆▆▅▂▄▅▅▅▅▅▅▆▅▅▅1163.03867.0-1507.02500.0-693.03098.03074.02001.0807.02544.0-2373.02761.02012.02797.01193.02095.02353.02086.01998.02014.02096.01776.01924.01647.01678.01396.0-1037.0687.01433.01286.01439.01286.01368.01239.01713.01604.01402.01006.0
us-gaap:IncomeTaxExpenseBenefit ▆▆▁▆▅▅▆▅▅▅▄▅▅▅█▆▆▆▇▆▆▆▆▆▆▆▄▅▆▆▆▆▆▆▅▅▅▅394.0312.0-1545.0187.046.088.0273.0117.066.088.0-547.014.029.014.01141.0464.0438.0375.0607.0416.0486.0422.0407.0408.0312.0374.0-227.0181.0335.0306.0311.0322.0300.0271.0173.019.0135.0123.0
us-gaap:InterestExpense █████▇▇▆▅▅▅▅▄▄▄▄▄▄▄▄▄▃▃▃▃▂▂▃▂▂▂▂▂▂▂▁615.0632.0629.0630.0632.0563.0559.0480.0358.0387.0380.0339.0320.0309.0299.0293.0284.0273.0316.0271.0245.0215.0208.0207.0172.0132.0139.0148.073.070.074.075.079.072.094.010.0NANA
us-gaap:InterestIncomeExpenseNonoperatingNet ▁▁▁▁▁▃▃▃▅▄▄▅▅▅▅▅▅▅▅▅▅▆▆▆▆▇▇▇▇▇▇▇▇▇▇███-606.0-622.0-618.0-620.0-614.0-428.0-455.0-420.0-309.0-325.0-319.0-302.0-272.0-251.0-252.0-252.0-253.0-247.0-290.0-250.0-225.0-200.0-199.0-197.0-164.0-126.0-129.0-128.0-69.0-65.0-68.0-69.0-75.0-66.0-88.01.02.01.0
 us-gaap:InterestIncomeExpenseNonoperatingNet us-gaap:DerivativeInstrumentRisk,us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome,us-gaap:StatementEquityComponents us-gaap:InterestRateSwap,us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome,us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest▇▇▇█▁7.07.07.08.03.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:InterestIncomeExpenseNonoperatingNet us-gaap:DerivativeInstrumentRisk,us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome,us-gaap:StatementEquityComponents us-gaap:TreasuryLock,us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome,us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest▃▃▃▃█▁-6.0-6.0-6.0-6.0-3.0-7.0NANA0.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:InterestIncomeExpenseNonoperatingNet us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship,us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome,us-gaap:StatementEquityComponents us-gaap:NetInvestmentHedging,us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome,us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent▄▄▂▃▄▇▇█▇▁▁▁▁5.04.02.03.05.08.08.010.09.00.00.00.00.0NANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:NetIncomeLoss ▄█▃▆▂▇▇▆▄▇▁▇▆▇▃▅▆▆▅▅▅▅▅▅▅▅766.03553.036.02308.0-738.03010.02801.01884.0741.02456.0-1826.02747.01983.02783.052.01631.01915.01711.01391.01598.01610.01354.01517.01239.01366.01022.0NANANANANANANANANANANANA
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest ▆▄▄█▁3.02.02.05.0-1.0NANANA0.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic ▄█▃▆▂▇▇▆▄▇▁▇▆▇▃▆▆▆▅▅▅▅▅▅▅▅▂▄▅▅▅▅▅▅▅▅▅▅749.03529.020.02291.0-756.02996.02788.01874.0733.02444.0-1822.02735.01973.02771.052.01623.01906.01702.01384.01590.01610.01354.01517.01239.01366.01022.0-810.0506.01098.0980.01128.0964.01068.0968.01540.01585.01267.0883.0
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted ▄█▃▆▂▇▇▆▄▇▁▇▆▇▃▆▆▆▅▅▅▅▅▅749.03529.020.02291.0-756.02996.02788.01874.0733.02444.0-1822.02735.01973.02771.052.01623.01906.01702.01384.01590.01602.01347.01509.01232.0NANANANANANANANANANANANANANA
us-gaap:OperatingIncomeLoss ██▇▇▄▇█▆▇▇▁▇▆▆▅▆▆▆▆▆▆▆▆▅▅▅▃▄▅▅▅▅▅▅▅▅▅▄4441.04103.03753.03255.0752.03603.03956.02617.03400.03010.0-2441.03159.02762.02903.01794.02705.02674.02419.02358.02361.02387.02278.02113.01885.01852.01687.0-415.0960.01515.01351.01535.01371.01453.01305.01821.01596.01422.0978.0
us-gaap:OtherComprehensiveIncomeLossNetOfTax █▆▇██▆▁▆▇192.0-178.0142.0176.0262.0-101.0-1068.0-37.025.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherNonoperatingIncomeExpense ▄█▁▇▆▇▇▇▄▇█▇▇█▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇█-2658.0395.0-4625.0-115.0-802.0-72.0-416.0-177.0-2278.0-135.0393.0-94.0-470.0153.0-29.0-349.0-62.0-73.0-80.0-101.0-51.00.012.0-28.04.0-1.03.029.0-8.03.0-13.0-5.04.015.0-30.013.0-11.037.0
us-gaap:ProfitLoss ▃█▂▆▁▇▇▅▃769.03555.038.02313.0-739.03010.02801.01884.0741.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost ▂▂▃▂▂▂▂▃▂▂█▂▂▂▂▂▂▂▂▂▂▁▂▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁1802.01782.01890.01706.01582.01379.01542.02285.01291.01289.06495.01268.01322.01244.01402.01222.01223.01135.01190.01106.01124.0946.01075.01418.0981.0811.0879.0812.0834.0772.0798.0714.0709.0634.0681.0813.0642.0642.0
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax █▇█▇▅▄▄▄▄▄▄▄▄▄▄▃▃▃▃▃▃▂▃▂▂▂▂▂▂▁▂▁▁▁▂▁▁▁13959.013010.013858.012902.010425.08619.08704.08479.08255.07828.08305.08236.08278.07934.07739.06995.06944.06538.06796.06432.06452.05958.06400.05944.05475.05040.05452.05019.04926.04563.05111.04658.04692.04329.05206.04508.04493.04173.0
us-gaap:Revenues █▇█▇▅▄▄▄▄▄▄▄▄▄▄▃▃▃▃▃▃▂▃▂▂▂▂▂▂▁▂▁▁▁▂▁▁▁13959.013010.013858.012902.010425.08619.08704.08479.08255.07828.08305.08236.08278.07934.07739.06995.06944.06538.06796.06432.06452.05958.06400.05944.05475.05040.05452.05019.04926.04563.05111.04658.04692.04329.05206.04508.04493.04173.0
us-gaap:SellingGeneralAndAdministrativeExpense ▇▆▇▆█▃▃▃▃▃▃▃▃▃▃▂▂▂▃▂▂▂▃▂▃▂▇▂▂▂▂▂▂▁▂▁▁▁3164.02842.03231.02846.03527.01695.01951.01657.01654.01680.01929.01919.01760.01791.01951.01452.01504.01368.01653.01381.01466.01355.01737.01474.01703.01473.03341.01595.01448.01340.01448.01261.01406.01237.01411.01085.01246.01247.0
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:Assets █████▅▅▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▂▃▃▁▁▁▁▁▁▁▁▁▁147972.0150501.0150565.0149621.0149530.091199.089115.059441.057142.056769.059352.066164.061641.069342.070786.068840.066994.065664.066099.066626.067211.053720.053050.054832.053855.026699.027547.028454.029045.028657.029198.028252.027910.027169.027008.0NANANA
us-gaap:LiabilitiesAndStockholdersEquity █████▅▅▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▂▃▃▁▁▁▁▁▁▁▁▁▁147972.0150501.0150565.0149621.0149530.091199.089115.059441.057142.056769.059352.066164.061641.069342.070786.068840.066994.065664.066099.066626.067211.053720.053050.054832.053855.026699.027547.028454.029045.028657.029198.028252.027910.027169.027008.0NANANA
us-gaap:StockholdersEquity ▇█▇██▁▁▁▁▁▁▃▃▅▅▅▅▅▅▅▅▅▅▅▅▄▄▅▅▅▅▅▅▄▃12569.013710.013076.015270.014708.0-7415.0-8172.0-8226.0-8566.0-7826.0-8446.0-2921.0-3375.03553.05097.06687.06009.04998.04636.06469.05640.04643.03945.04863.05504.01377.01742.04645.05218.04697.04492.03577.03558.02957.0-350.0NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:AssetsCurrent ▃▃▃▃▂██▂▁▁▂▂▁▂▂▂▂▁▁▁▂▂▁▂▂▁▁▂▂▂▂▁▁▁▁25999.026569.024173.023009.021256.051758.049519.020166.015100.014413.016945.018465.013845.020444.021223.018930.016962.015547.016187.016290.016791.016622.016314.017912.016877.015408.016088.017555.017794.017329.017848.016543.015662.014923.015354.0NANANA
us-gaap:CashAndCashEquivalentsAtCarryingValue ▂▃▂▂▂██▃▂▂▂▂▂▃▃▂▂▂▂▂▂▂▂▃▂▂▂▂▃▂▃▃▂▂▂▁▁▁8546.09755.08449.07890.06017.041142.039924.010648.05172.04897.07289.08015.03547.09007.09303.08446.06088.04740.05100.06218.06327.07556.08399.09223.07400.07906.08348.07719.09086.08140.09595.08975.08743.06979.05901.02761.074.041.0
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents ▂▂▂▂▁██▂▁▁▁8546.09755.08449.07890.06017.041142.039924.010648.05172.04897.07289.0NANANA9303.0NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:ShortTermInvestments ▇▁▂█▁54.022.030.060.023.0NA0.00.0244.0331.0772.0770.0196.0467.0486.01108.01117.01508.01323.01732.01675.01044.08.026.0879.018.026.09.01160.0960.0300.0621.011.0500.02075.0NANANA
us-gaap:AccountsReceivableNetCurrent ██▇▆▆▃▂▂▂▂▂▂▂▃▂▁▁▁▁▁▁▁▁9914.09588.08822.08416.08354.06362.05428.05529.05482.05680.05384.05780.05793.05841.05088.04891.04859.04677.04758.04999.05048.04753.04730.0NANANANANANANANANANANANANANANA
us-gaap:InventoryNet ▆▆▆▇█▃▃▃▃▃▂▃▂▃▂▃▂▂▂▂▃▃▃▃▂▁▁▁▁▁▁▁▁▁▁3386.03272.03310.03474.04059.01844.01813.01929.01895.01702.01605.01786.01580.01738.01605.01785.01582.01427.01444.01630.01756.01789.01719.01841.01623.01022.01124.01008.01048.01104.01150.01172.01085.01037.01091.0NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:NoncurrentAssets NANA5248.0NANANA2962.0NANANA2883.0NANANA2803.0NANANA2604.0NANANA2600.0NANANA2500.0NANANA2300.0NANANA2200.0NANANA
 us-gaap:NoncurrentAssets us-gaap:StatementGeographical abbv:AllOtherCountriesNANA360.0NANANA290.0NANANA291.0NANANA320.0NANANA278.0NANANA184.0NANANANANANANANANANANANANANANA
 us-gaap:NoncurrentAssets us-gaap:StatementGeographical abbv:UnitedStatesAndPuertoRicoNANA3354.0NANANA2026.0NANANA1993.0NANANA1862.0NANANA1822.0NANANA1900.0NANANA1800.0NANANA1600.0NANANA1600.0NANANA
 us-gaap:NoncurrentAssets us-gaap:StatementGeographical srt:EuropeNANA1534.0NANANA646.0NANANA599.0NANANA621.0NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:PropertyPlantAndEquipmentGross ███▇▇▄▄▄▄▄▄▄▄▄▃▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▁▁▁▁10816.010887.010859.010391.010327.08250.08188.08492.08443.08370.08396.08449.08214.08231.08071.07894.07786.07596.07526.07710.07601.07489.07334.07281.07172.06988.07105.07055.07147.07016.06909.06790.06646.06545.06542.0NANANA
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment ███▇▇▆▆█▇▇▇▇▇▇▆▆▅▄▄▅▄▄▃▃▃▂▃▃▃▃▃▂▂▁▁5655.05694.05611.05405.05419.05289.05226.05598.05564.05510.05513.05499.05427.05403.05268.05197.05129.04984.04922.05072.04983.04892.04769.04735.04655.04557.04620.04623.04760.04683.04611.04546.04433.04345.04295.0NANANA
us-gaap:AmortizationOfIntangibleAssets ██▇█▆▂▂▂▂▂▂▂▂▂▂▂▂▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁2000.02009.01838.02100.01400.0444.0391.0389.0388.0385.0320.0320.0324.0330.0268.0268.0269.0271.0210.0208.0181.0165.0140.0125.086.068.096.098.099.0110.0101.0137.0136.0135.0136.0134.0176.0179.0
us-gaap:PropertyPlantAndEquipmentNet ███▇▇▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▁▁▁▁▁▁▁5161.05193.05248.04986.04908.02961.02962.02894.02879.02860.02883.02950.02787.02828.02803.02697.02657.02612.02604.02638.02618.02597.02565.02546.02517.02431.02485.02432.02387.02333.02298.02244.02213.02200.02247.0NANANA
us-gaap:LongTermInvestments ▂▂▂▂▂▁▁▁▆▆▆▆▆██▇██▇▅▆▂▁▁▁▁▁▁▁▁▁▁▁▁▁266.0305.0293.0246.0225.078.093.0131.01473.01477.01420.01463.01505.02057.02090.01971.02052.02123.01783.01378.01400.0387.0145.074.0134.093.092.0124.0130.0119.0118.0123.0121.0118.0119.0NANANA
us-gaap:Goodwill ▆▆▆██▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▂▂▂▂▁▁▁▁▁▁▁▁▁▁32398.032349.033124.042801.042669.015561.015604.015537.015642.015606.015663.015718.015692.015880.015785.015748.015652.015490.015416.015657.015507.013274.013168.013243.013209.05534.05862.06002.06244.06271.06277.06199.06120.06060.06130.0NANANA
us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill ▅▇█▁▁1550.01727.01877.01040.01040.0NA0.00.01030.04920.04920.09990.09990.09990.09990.09990.09990.09990.09990.09990.010185.0393.07573.07589.07579.0407.0445.0446.0446.0447.0447.0446.0446.0420.0420.0NANANA
us-gaap:IntangibleAssetsNetExcludingGoodwill ███▇▇▂▂▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▁▁▁▁▁▁▁▁▁▁79340.081293.082876.074643.076463.018203.018649.019036.020459.020846.021233.026625.026903.027230.027559.028167.028366.028629.028897.029113.029450.019512.019709.019822.019937.01478.01513.01540.01695.01802.01890.01993.02101.02153.02323.0NANANA
us-gaap:FiniteLivedIntangibleAssetsNet ███▇█▃▃▃▃▂▂▂▂▂▂▂▃▃▃▃▃▃▂▂▂▁▁▁▁▁▁▁▁▁▁77790.079566.080999.073603.075423.018203.018649.019036.019429.015926.016313.016635.016913.017240.017569.018177.018376.018639.018907.019123.019265.019119.012136.012233.012358.01071.01068.01094.01249.01355.01443.01547.01655.01733.01903.0NANANA
 us-gaap:OperatingLeaseRightOfUseAsset us-gaap:BalanceSheetLocation us-gaap:OtherNoncurrentAssetsNANA895.0NANANA344.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherAssetsNoncurrent ███▆▇▄▄▃▂▂▂▁▁▁▂▂▂▂▂▂▂▂▂▂▂▃▂▁▁▁▁▂▃▃▁4808.04792.04851.03936.04009.02638.02288.01677.01589.01567.01208.0943.0909.0903.01326.01327.01305.01263.01212.01550.01445.01328.01149.01235.01181.01755.01507.0801.0795.0803.0767.01150.01693.01715.0835.0NANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementFrequency us-gaap:FairValueInputsLevel1,us-gaap:FairValueMeasurementsRecurring▃██▇▁110.0147.0149.0138.095.0NA24.0NANANA4.0NANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementFrequency us-gaap:FairValueInputsLevel2,us-gaap:FairValueMeasurementsRecurring█▇▇▆▁11.010.010.08.00.0NA0.0NANANA0.0NANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByMeasurementFrequency us-gaap:FairValueMeasurementsRecurring▄██▇▁121.0157.0159.0146.095.0NA24.0NANANA4.0NANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent ███▇▇▄▄▄▄▄▄▄▃▃▃▃▂▂▃▃▂▂▂▂▂▁▂▁▁▁▁▁▁▁▁20783.020604.020159.019404.019275.012709.011832.012217.011300.011826.011931.011366.010694.010677.010226.09212.08839.08419.09379.09077.08755.08239.08463.08045.07251.06460.06954.06312.06046.06196.06448.06441.06373.06330.05734.0NANANA
us-gaap:AccountsPayableCurrent NANA2276.0NANANA1452.0NANANA1546.0NANANA1474.0NANANA1407.0NANANA1597.0NANANA881.0NANANA933.0NANANA556.0NANANA
us-gaap:DividendsPayableCurrent NANA2335.0NANANA1771.0NANANA1607.0NANANA1143.0NANANA1028.0NANANA924.0NANANA791.0NANANA643.0NANANANANANANA
us-gaap:LiabilitiesCurrent ▇█▇▆▆▄▄▄▄▃▄▃▄▄▄▃▃▂▂▂▂▂▂▂▂▂▂▁▁▁▁▁▁▁▁28684.031951.028661.024181.024646.016471.015585.017493.016941.013904.017239.015387.017224.017058.016641.013033.012259.08844.09781.09103.09272.010662.010894.08813.011258.011050.011400.06635.06317.06216.06879.06875.06805.06766.06776.0NANANA
 us-gaap:OperatingLeaseLiabilityCurrent us-gaap:BalanceSheetLocation us-gaap:AccountsPayableAndAccruedLiabilitiesNANA175.0NANANA109.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherAccruedLiabilitiesCurrent NANA6208.0NANANA2971.0NANANA3748.0NANANA3263.0NANANA2979.0NANANA2544.0NANANA1918.0NANANA1531.0NANANA1718.0NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:LongTermDebt NANA84948.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument abbv:AllerganSeniorNotesAcquiredNANANA20426.020960.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:SeniorEuroNotesDue2020AtFloatingRates,us-gaap:SeniorNotesNANANA821.0788.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:SeniorEuroNotesDue2021At0.500Percent,us-gaap:SeniorNotesNANANA879.0845.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:SeniorEuroNotesDue2023At1.500Percent,us-gaap:SeniorNotesNANANA586.0563.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:SeniorEuroNotesDue2024At1.250Percent,us-gaap:SeniorNotesNANANA821.0788.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:SeniorEuroNotesDue2028At2.625Percent,us-gaap:SeniorNotesNANANA586.0563.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:SeniorEuroNotesDue2029At2.125Percent,us-gaap:SeniorNotesNANANA645.0619.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:DebtAndCapitalLeaseObligations NANA86022.0NANANA66728.0NANANA36611.0NANANA36968.0NANANA36465.0NANANA31265.0NANANA14586.0NANANA14310.0NANANA14652.0NANANA
 us-gaap:DebtAndCapitalLeaseObligations us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:FloatingRateTermLoanTrancheDueMay2023,us-gaap:LoansPayableNANA1000.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:DebtAndCapitalLeaseObligations us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:FloatingRateTermLoanTrancheDueMay2025,us-gaap:LoansPayableNANA2000.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:DebtAndCapitalLeaseObligations us-gaap:DebtInstrument,us-gaap:LongtermDebtType abbv:SeniorNotesIssuedin2015,us-gaap:SeniorNotesNANA10000.0NANANA13700.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LongTermDebtAndCapitalLeaseObligations ▇▇███▆▆▃▃▃▃▄▃▃▃▃▃▄▄▄▄▃▃▃▃▁▁▁▁▁▁▁▁▁▁74237.074183.077554.082282.082061.063284.062975.033126.031619.035066.035002.036487.030579.030906.030953.033974.033817.036526.036440.037284.037328.029490.029240.031359.027116.010683.010565.014469.014470.014386.014292.014375.014326.014601.014630.0NANANA
us-gaap:DeferredIncomeTaxLiabilitiesNet ▆▆▆▇█▁▁3661.03768.03646.04485.04785.0959.01130.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent NANA3413.0NANANA2949.0NANANA1840.0NANANA2740.0NANANA2085.0NANANA1949.0NANANA2220.0NANANA1628.0NANANA979.0NANANA
 us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent us-gaap:RetirementPlanType us-gaap:OtherPostretirementBenefitPlansDefinedBenefitNANA772.0NANANA1032.0NANANA546.0NANANA798.0NANANA613.0NANANANANANANANANANANANANANANANANANANA
 us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent us-gaap:RetirementPlanType us-gaap:PensionPlansDefinedBenefitNANA2641.0NANANA1917.0NANANA1294.0NANANA1942.0NANANA1472.0NANANANANANANANANANANANANANANANANANANA
us-gaap:MinorityInterest █▆▃▁▇25.023.021.019.024.0NA0.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherLiabilitiesNoncurrent ███▇▇▅▁28796.026866.027607.023384.023306.017900.01222.0NANANA1307.0NANANA1241.0NANANA1160.0NANANA844.0NANANA990.0NANANA1337.0NANANA900.0NANANA
 us-gaap:OperatingLeaseLiabilityNoncurrent us-gaap:BalanceSheetLocation us-gaap:OtherNoncurrentLiabilitiesNANA832.0NANANA251.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo NANA178.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree NANA140.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour NANA111.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive NANA96.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive NANA394.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:StockholdersEquity ▇█▇██▁▁▁▁▁▁▃▃▅▅▅▅▅▅▅▅▅▅▅▅▄▄▅▅▅▅▅▅▄▃12569.013710.013076.015270.014708.0-7415.0-8172.0-8226.0-8566.0-7826.0-8446.0-2921.0-3375.03553.05097.06687.06009.04998.04636.06469.05640.04643.03945.04863.05504.01377.01742.04645.05218.04697.04492.03577.03558.02957.0-350.0NANANA
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ▇█▇██▁▁▁▁▁▁12594.013733.013097.015289.014732.0-7415.0-8172.0-8226.0-8566.0-7826.0-8446.0NANANA5097.0NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:AdditionalPaidInCapitalCommonStock █████▇▇▇▇▇▆▆▆▆▆▆▆▆▆▆▆▆▆▆▅▁▁▁▁▁▁17936.017712.017384.017148.016953.015401.015193.015112.015028.014940.014756.014680.014596.014519.014270.014154.014015.013889.013678.013540.013046.013293.013080.013005.012421.04403.04194.04083.03996.03905.03671.0NANANANANANANA
us-gaap:RetainedEarningsAccumulatedDeficit ▁▃▂▄▄▇▆▅▄▅▄█▇▆▇█▇▆▅▅▄▃▃▂▂▁▁▃▃▂▂740.02292.01055.03335.03130.05973.04717.03673.03384.04234.03368.06789.05495.04977.05459.06547.05951.05063.04378.04011.03349.02673.02248.01654.01256.0739.0535.02131.02299.01874.01567.0NANANANANANANA
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▂▂▂▂▂▁▁▃▄▃▄▃▃▃▃▃▃▃▃▄▄▄▃▄▄▄▄▇███▇▆▆█-3103.0-3295.0-3117.0-3259.0-3435.0-3697.0-3596.0-2528.0-2491.0-2516.0-2480.0-2559.0-2639.0-2630.0-2727.0-2613.0-2548.0-2542.0-2586.0-2340.0-2390.0-2423.0-2561.0-2499.0-2374.0-2467.0-2031.0-913.0-420.0-426.0-442.0-981.0-1169.0-1237.0-350.0NANANA
us-gaap:TreasuryStockValue ▂▂▂▁▁██████▇▇▅▄▄▄▄▄▃▃▃▃▃▃▁▁▁▁▁▁3022.03017.02264.01972.01958.025110.024504.024501.024505.024502.024108.021849.020845.013331.011923.011419.011427.011430.010852.08760.08383.08918.08839.07314.05816.01314.0972.0672.0673.0672.0320.0NANANANANANANA
us-gaap:MinorityInterest █▆▃▁▇25.023.021.019.024.0NA0.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities ▆▆▆█▃▄▃▆▂▃▄▆▃▂▂▃▁▁4890.04877.04854.05830.03089.03815.03275.04555.02477.03017.03392.04524.02866.02645.02584.03271.02003.02102.0NA1454.01918.02128.0NANANANANANANANANANANANANANANANA
us-gaap:NetCashProvidedByUsedInInvestingActivities ████▁█████████████-242.0-342.0-627.0-1149.0-35652.0-129.0-615.01378.0-140.0-27.0-283.0-963.0687.0-447.0201.0-109.0318.0-684.0NA-199.0-4298.0-1458.0NANANANANANANANANANANANANANANANA
us-gaap:NetCashProvidedByUsedInFinancingActivities ▂▂▂▂▂▂█▃▂▂▂▃▁▂▂▃▃▂▂▂▃▃-5884.0-3174.0-3695.0-2814.0-2570.0-2422.026602.0-441.0-2070.0-5383.0-3825.0916.0-8978.0-2509.0-1928.0-810.0-980.0-1794.0-2502.0-1371.01164.0-1219.0NANANANANANANANANANANANANANANANA
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect ▅▅▅▅▁▅█▅▅▅-1209.01306.0559.01873.0-35125.01218.029276.05476.0275.0-2392.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:DeferredIncomeTaxExpenseBenefit ▇▇▁▆▇▇█▇-91.0-28.0-1827.0-241.0-76.0-181.0199.0-149.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:IncreaseDecreaseInAccountsReceivable ▅▇▅▃▁█▃▄▂▅▂▃▄▆▄▃▄▃▃▃▅▃▄▄▃▆296.0866.0355.031.0-482.01025.0-133.0111.0-220.0316.0-215.01.0124.0681.0228.0-4.0133.034.0-58.0-65.0275.0-81.0234.0254.044.0544.0NANANANANANANANANANANANA
us-gaap:IncreaseDecreaseInInventories ▅▇▂▂▇▅▂▆▆▆▂▆▆▅▁▆▅▃▅▄▄▄▄█▅▅▇▅▃▃▄▄▅▄▅▅▅▄62.0187.0-153.0-111.0197.0107.0-170.0113.0160.0128.0-141.0176.0120.071.0-212.0120.070.0-71.066.0-28.019.0-19.0-12.0286.085.075.0223.077.0-47.0-50.0-30.036.061.0-11.0104.043.049.07.0
us-gaap:NetCashProvidedByUsedInOperatingActivities ▆▆▆█▃▄▃▆▂▃▄▆▃▂▂▃▁▁4890.04877.04854.05830.03089.03815.03275.04555.02477.03017.03392.04524.02866.02645.02584.03271.02003.02102.0NA1454.01918.02128.0NANANANANANANANANANANANANANANANA
us-gaap:NetIncomeLoss ▄█▃▆▂▇▇▆▄▇▁▇▆▇▃▅▆▆▅▅▅▅▅▅▅▅766.03553.036.02308.0-738.03010.02801.01884.0741.02456.0-1826.02747.01983.02783.052.01631.01915.01711.01391.01598.01610.01354.01517.01239.01366.01022.0NANANANANANANANANANANANA
us-gaap:ProfitLoss ▃█▂▆▁▇▇▅▃769.03555.038.02313.0-739.03010.02801.01884.0741.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:ShareBasedCompensation ▅█▄▅▇▇▂▂▃▆▂▂▃▆▂▂▂▄▂▂▂▄▂▂▂▄▁▁▂▃▁▁▁▃▁▁▁▃159.0269.0136.0162.0236.0219.079.075.087.0189.070.075.085.0191.077.071.076.0141.075.069.071.0138.053.055.055.0119.043.044.048.0106.037.042.046.087.031.030.035.091.0
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:NetCashProvidedByUsedInInvestingActivities ████▁█████████████-242.0-342.0-627.0-1149.0-35652.0-129.0-615.01378.0-140.0-27.0-283.0-963.0687.0-447.0201.0-109.0318.0-684.0NA-199.0-4298.0-1458.0NANANANANANANANANANANANANANANANA
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ▆▆█▆▆▄▅▅▄▄▄█▄▄▆▄▄▄▄▄▄▄▅▄▄▅▅▆▅▅▅▅▄▃▄▁▄▅195.0188.0279.0217.0177.0125.0163.0154.0128.0107.0123.0282.0114.0119.0182.0126.0126.095.0114.0113.0131.0121.0145.0127.0115.0145.0153.0180.0142.0137.0151.0133.0119.088.095.0-18.094.0162.0
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
us-gaap:NetCashProvidedByUsedInFinancingActivities ▂▂▂▂▂▂█▃▂▂▂▃▁▂▂▃▃▂▂▂▃▃-5884.0-3174.0-3695.0-2814.0-2570.0-2422.026602.0-441.0-2070.0-5383.0-3825.0916.0-8978.0-2509.0-1928.0-810.0-980.0-1794.0-2502.0-1371.01164.0-1219.0NANANANANANANANANANANANANANANANA
us-gaap:ProceedsFromIssuanceOfLongTermDebt NANA0.00.0NANA29948.0NANANA0.0NANANA0.00.0NANA3856.00.0NANA4000.05.0NANANANANANANANANANANANANANA
us-gaap:PaymentsOfDividends ██▇▇▆▆▅▅▅▅▄▄▅▃▃▃▃▃▂▂▂▂▂▂▂▂▁▁▁▁▁▁▁▁2310.02322.02101.02100.01752.01763.01595.01591.01592.01588.01451.01461.01531.01137.01030.01026.01024.01027.0933.0933.0927.0924.0840.0850.0818.0786.0674.0673.0673.0641.0641.0640.0638.0636.0NANANANA
us-gaap:PaymentsForRepurchaseOfCommonStock ▁▂▁▁▁▂▁▁▁▂▃▂█▂▁▁▁▂▃▁▅▁▂▂▆▁▁▁▁▁▁▁▁▁10.0787.0296.020.019.0643.02.04.03.0620.02058.01009.07516.01431.0505.05.05.0895.01824.0-3.03803.0409.01225.0998.05002.0342.0300.0-1.024.0329.0201.0-2.024.097.0NANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31

Shares Outstanding

us-gaap:SharesOutstanding us-gaap:StatementEquityComponents

us-gaap:SharesOutstanding

us-gaap:CommonStock


Shares
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value1767176617651765176414771479147914781478147915041514158715921593161015911587
Percentage of SharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding


Weighted
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-31
Value17761775177416471484148314841483151515721596160316001603164016321625166416331608161016081609160516091605157715771577
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic


Weighted
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-31
Value17691769176916471481148114801480151115681591159715951597163216241616165216201595159515941595159015891588157715771577
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareBasic


Earnings
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value0.422.00.011.3-0.462.021.881.270.491.65-1.231.811.261.740.031.021.21.070.860.970.990.830.930.750.840.64-0.510.320.690.610.70.60.670.610.981.010.80.56
Percentage of EarningsPerShareBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted

us-gaap:EarningsPerShareDiluted


Earnings
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value0.421.990.011.29-0.462.021.881.260.491.65-1.231.811.261.740.031.011.191.060.850.970.980.830.920.740.830.63-0.510.310.680.610.70.60.660.60.981.010.80.56
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Allocated Share Based Compensation Expense

us-gaap:AllocatedShareBasedCompensationExpense

us-gaap:AllocatedShareBasedCompensationExpense


Allocated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value15926913616223621979758718970758519177717614175471371385355551194344491063741468731303591
Percentage of AllocatedShareBasedCompensationExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.12.11.01.32.32.50.90.91.12.40.80.91.02.41.01.01.12.21.10.72.12.30.80.91.02.40.80.91.02.30.70.91.02.00.60.70.82.2

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:IncomeStatementLocation

us-gaap:CostOfSales


Allocated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-06-302014-03-312013-06-302013-03-31
Value10.02010.01111155.04.05.0154.07.0124.03.07.010.03.03.06.08.03.04.06.07.06.04.07.05.0
Percentage of AllocatedShareBasedCompensationExpense6.37.47.46.84.76.86.35.35.77.95.79.314.12.13.99.913.22.14.012.85.82.27.510.912.712.23.815.25.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.20.10.10.10.20.10.00.10.20.00.10.10.10.00.10.10.00.00.10.10.10.10.10.10.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:CostOfSales0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ResearchAndDevelopmentExpense


Allocated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-06-302014-03-312013-06-302013-03-31
Value478747545492353133723032357232303364326.0976324242616341325
Percentage of AllocatedShareBasedCompensationExpense29.632.334.633.322.942.044.341.337.938.142.942.741.237.741.642.343.445.442.712.870.845.745.343.647.332.732.128.328.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.70.30.40.51.10.40.40.40.90.40.40.40.90.40.40.51.00.50.11.51.10.40.40.50.30.70.30.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ResearchAndDevelopmentExpense0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:SellingGeneralAndAdministrativeExpenses


Allocated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-06-302014-03-312013-06-302013-03-31
Value1021627997171112394049102363638115423433744035327225252227682657
Percentage of AllocatedShareBasedCompensationExpense64.260.258.159.972.551.149.453.356.354.051.448.044.760.254.547.943.452.553.374.523.452.247.245.540.055.164.256.565.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.71.20.60.81.61.30.40.50.61.30.40.40.51.40.50.50.51.10.60.50.51.20.40.40.40.51.50.61.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:SellingGeneralAndAdministrativeExpenses0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTax


Comprehensive
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value95833751782484-476.02909173318477662420-1747.0282719742880-62.01566190917551145164816431492145511141459586-1928.0131104996164711521136763153018667471103
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.925.91.319.3-4.633.819.921.89.330.9-21.034.323.836.3-0.822.427.526.816.825.625.525.022.718.726.611.6-35.40.322.421.832.224.724.217.629.441.416.626.4

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest


Comprehensive
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value3000000.02000000.02000000.05000000.0-1000000.00
Percentage of ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest100.0100.0100.0100.0100.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.0-0.00.0

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest


Comprehensive
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value96133771802489-477.0290917331847766
Percentage of ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.926.01.319.3-4.633.819.921.89.3

Cost Of Goods And Services Sold

us-gaap:CostOfGoodsAndServicesSold

us-gaap:CostOfGoodsAndServicesSold


Cost
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value4523421346845050371119422006192018191694202218351934192722811616
Percentage of CostOfGoodsAndServicesSold100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax32.432.433.839.135.622.523.022.622.021.624.322.323.424.329.523.1

us-gaap:CostOfGoodsAndServicesSold us-gaap:DerivativeInstrumentRisk, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:ForeignExchangeForward, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Cost
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-312019-09-302019-06-30
Value2212-8.0-15.00.0-48.0-42.0-37.0
Percentage of CostOfGoodsAndServicesSold0.50.3-0.2-0.30.0-2.4-2.2-2.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.1-0.1-0.10.0-0.6-0.5-0.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ForeignExchangeForward us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest0.00.00.00.00.00.00.00.0

Costs And Expenses

us-gaap:CostsAndExpenses

us-gaap:CostsAndExpenses


Costs
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value9518890710105964796735016474858624855481810746507755165031594542904270411944384071406536804287405936233353586740593411321235763287323930243385291230713195
Percentage of CostsAndExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax68.268.572.974.892.858.254.569.158.861.5129.461.666.663.476.861.361.563.065.363.363.061.867.068.366.266.5107.680.969.270.470.070.669.069.965.064.668.476.6

Gross Profit

us-gaap:GrossProfit

us-gaap:GrossProfit


Gross
Period End2020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value917466986559643661346283640163446007545953795416492252414928504745894925477745594098433339253813346338293566363831763941349434203017
Percentage of GrossProfit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax66.277.077.478.078.475.777.776.675.770.576.978.075.377.176.678.277.077.080.483.381.379.578.277.475.974.976.677.573.475.777.576.172.3

Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments


Income
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value11633867-1507.02500-693.03098307420018072544-2373.0276120122797119320952353208619982014209617761924164716781396-1037.06871433128614391286136812391713160414021006
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.329.7-10.919.4-6.635.935.323.69.832.5-28.633.524.335.315.429.933.931.929.431.332.529.830.127.730.627.7-19.013.729.128.228.227.629.228.632.935.631.224.1

Income Tax Expense Benefit

us-gaap:IncomeTaxExpenseBenefit

us-gaap:IncomeTaxExpenseBenefit


Income
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value394312-1545.018746882731176688-547.01429141141464438375607416486422407408312374-227.018133530631132230027117319135123
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.82.4-11.11.40.41.03.11.40.81.1-6.60.20.40.214.76.66.35.78.96.57.57.16.46.95.77.4-4.23.66.86.76.16.96.46.33.30.43.02.9

us-gaap:IncomeTaxExpenseBenefit us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:NetInvestmentHedging, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent


Income
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value1.01.00.01.01.02.02.02.02.00.00.00.00.0
Percentage of IncomeTaxExpenseBenefit0.30.3-0.00.52.22.30.71.73.00.0-0.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NetInvestmentHedging us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:IncomeTaxExpenseBenefit us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Income
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-3.0-2.03.03.00.01.04.03.02.0
Percentage of IncomeTaxExpenseBenefit-0.8-0.6-0.21.60.01.11.52.63.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.0-0.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest0.00.00.00.00.00.00.00.00.0

Interest Expense

us-gaap:InterestExpense

us-gaap:InterestExpense


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
Value6156326296306325635594803583873803393203092992932842733162712452152082071721321391487370747579729410.0
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.44.94.54.96.16.56.45.74.34.94.64.13.93.93.94.24.14.24.64.23.83.63.23.53.12.62.52.91.51.51.41.61.71.71.80.2

Interest Income Expense Nonoperating Net

us-gaap:InterestIncomeExpenseNonoperatingNet

us-gaap:InterestIncomeExpenseNonoperatingNet


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value-606.0-622.0-618.0-620.0-614.0-428.0-455.0-420.0-309.0-325.0-319.0-302.0-272.0-251.0-252.0-252.0-253.0-247.0-290.0-250.0-225.0-200.0-199.0-197.0-164.0-126.0-129.0-128.0-69.0-65.0-68.0-69.0-75.0-66.0-88.01.02.01.0
Percentage of InterestIncomeExpenseNonoperatingNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-4.3-4.8-4.5-4.8-5.9-5.0-5.2-5.0-3.7-4.2-3.8-3.7-3.3-3.2-3.3-3.6-3.6-3.8-4.3-3.9-3.5-3.4-3.1-3.3-3.0-2.5-2.4-2.6-1.4-1.4-1.3-1.5-1.6-1.5-1.70.00.00.0

us-gaap:InterestIncomeExpenseNonoperatingNet us-gaap:DerivativeInstrumentRisk, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:InterestRateSwap, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value7.07.07.08.03.0
Percentage of InterestIncomeExpenseNonoperatingNet-1.2-1.1-1.1-1.3-0.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:InterestRateSwap us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest0.00.00.00.00.0

us-gaap:TreasuryLock, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-06-30
Value-6.0-6.0-6.0-6.0-3.0-7.00.0
Percentage of InterestIncomeExpenseNonoperatingNet1.01.01.01.00.51.6-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.0-0.0-0.0-0.0-0.0-0.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:TreasuryLock us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest0.00.00.00.00.00.00.0

us-gaap:InterestIncomeExpenseNonoperatingNet us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:NetInvestmentHedging, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value5.04.02.03.05.08.08.010.09.00.00.00.00.0
Percentage of InterestIncomeExpenseNonoperatingNet-0.8-0.6-0.3-0.5-0.8-1.9-1.8-2.4-2.9-0.0-0.0-0.0-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.10.10.10.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NetInvestmentHedging us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent0.00.00.00.00.00.00.00.00.00.00.00.00.0

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value7663553362308-738.03010280118847412456-1826.02747198327835216311915171113911598161013541517123913661022
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.527.30.317.9-7.134.932.222.29.031.4-22.033.424.035.10.723.327.626.220.524.825.022.723.720.824.920.3

us-gaap:NetIncomeLoss us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:NetInvestmentHedging, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value4.03.02.02.04.06.06.08.07.00.00.00.00.0
Percentage of NetIncomeLoss0.50.15.60.1-0.50.20.20.40.90.0-0.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.10.10.10.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NetInvestmentHedging us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NetIncomeLoss us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-20.0-11.04.010.03.06.0483935
Percentage of NetIncomeLoss-2.6-0.311.10.4-0.40.21.72.14.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.10.00.10.00.10.60.50.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest0.00.00.00.00.00.00.00.00.0

us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value7663553362308-738.03010280118847412456-1826.0274719832783
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.527.30.317.9-7.134.932.222.29.031.4-22.033.424.035.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Net Income Loss Attributable To Noncontrolling Interest

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value3000000.02000000.02000000.05000000.0-1000000.00
Percentage of NetIncomeLossAttributableToNoncontrollingInterest100.0100.0100.0100.0100.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.0-0.00.0

Net Income Loss Available To Common Stockholders Basic

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value7493529202291-756.02996278818747332444-1822.02735197327715216231906170213841590161013541517123913661022-810.0506109898011289641068968154015851267883
Percentage of NetIncomeLossAvailableToCommonStockholdersBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.427.10.117.8-7.334.832.022.18.931.2-21.933.223.834.90.723.227.426.020.424.725.022.723.720.824.920.3-14.910.122.321.522.120.722.822.429.635.228.221.2

Net Income Loss Available To Common Stockholders Diluted

us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted

us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value7493529202291-756.02996278818747332444-1822.027351973277152162319061702138415901602134715091232
Percentage of NetIncomeLossAvailableToCommonStockholdersDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.427.10.117.8-7.334.832.022.18.931.2-21.933.223.834.90.723.227.426.020.424.724.822.623.620.7

Operating Income Loss

us-gaap:OperatingIncomeLoss

us-gaap:OperatingIncomeLoss


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value444141033753325575236033956261734003010-2441.0315927622903179427052674241923582361238722782113188518521687-415.0960151513511535137114531305182115961422978
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax31.831.527.125.27.241.845.530.941.238.5-29.438.433.436.623.238.738.537.034.736.737.038.233.031.733.833.5-7.619.130.829.630.029.431.030.135.035.431.623.4

Other Comprehensive Income Loss Net Of Tax

us-gaap:OtherComprehensiveIncomeLossNetOfTax

us-gaap:OtherComprehensiveIncomeLossNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value192-178.0142176262-101.0-1068.0-37.025
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.4-1.41.01.42.5-1.2-12.3-0.40.3

us-gaap:OtherComprehensiveIncomeLossNetOfTax us-gaap:StatementEquityComponents

abbv:AccumulatedNetGainLossFromNetInvestmentHedges


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-114.0374-344.0-314.0-213.072-110.0156
Percentage of OtherComprehensiveIncomeLossNetOfTax-59.4-210.1-242.3-178.4-81.3-71.310.3-421.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.82.9-2.5-2.4-2.00.8-1.31.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:AccumulatedNetGainLossFromNetInvestmentHedges0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value5079-236.0354356-1321.033
Percentage of OtherComprehensiveIncomeLossNetOfTax26.0-44.4-166.219.916.4-55.4123.7-89.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.6-1.70.30.40.6-15.20.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value244-677.0785512441-227.0190-256.0
Percentage of OtherComprehensiveIncomeLossNetOfTax127.1380.3552.8290.9168.3224.8-17.8691.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.7-5.25.74.04.2-2.62.2-3.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value1246-63.0-57.0-9.0-2.017331
Percentage of OtherComprehensiveIncomeLossNetOfTax6.2-25.8-44.4-32.4-3.42.0-16.2-83.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.4-0.5-0.4-0.1-0.02.00.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value192-178.0142176262-101.0-1068.0-37.025
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.4-1.41.01.42.5-1.2-12.3-0.40.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.0

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value192-178.0142176262-101.0-1068.0-37.0
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.4-1.41.01.42.5-1.2-12.3-0.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.0

Other Nonoperating Income Expense

us-gaap:OtherNonoperatingIncomeExpense

us-gaap:OtherNonoperatingIncomeExpense


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value-2658.0395-4625.0-115.0-802.0-72.0-416.0-177.0-2278.0-135.0393-94.0-470.0153-29.0-349.0-62.0-73.0-80.0-101.0-51.00.012-28.04.0-1.03.029-8.03.0-13.0-5.04.015-30.013-11.037
Percentage of OtherNonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-19.03.0-33.4-0.9-7.7-0.8-4.8-2.1-27.6-1.74.7-1.1-5.71.9-0.4-5.0-0.9-1.1-1.2-1.6-0.80.00.2-0.50.1-0.00.10.6-0.20.1-0.3-0.10.10.3-0.60.3-0.20.9

Profit Loss

us-gaap:ProfitLoss

us-gaap:ProfitLoss


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value7693555382313-739.0301028011884741
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.527.30.317.9-7.134.932.222.29.0

Research And Development Expense Excluding Acquired In Process Cost

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost


Research
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value18021782189017061582137915422285129112896495126813221244140212221223113511901106112494610751418981811879812834772798714709634681813642642
Percentage of ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.913.713.613.215.216.017.726.915.616.578.215.416.015.718.117.517.617.417.517.217.415.916.823.917.916.116.116.216.916.915.615.315.114.613.118.014.315.4

Revenue From Contract With Customer Excluding Assessed Tax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value1395913010138581290210425861987048479825578288305823682787934773969956944653867966432645259586400594454755040545250194926456351114658469243295206450844934173
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax abbv:KeyProductPortfolio, us-gaap:ProductOrService

abbv:Aesthetics, abbv:BotoxCosmetic


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value5844774933932260.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.23.73.63.02.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.23.73.63.02.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:BotoxCosmetic100.0100.0100.0100.0100.00.0

abbv:Aesthetics, abbv:JuvedermCollection


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value4283213312741130.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.12.52.42.11.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.12.52.42.11.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:JuvedermCollection100.0100.0100.0100.0100.00.0

abbv:Aesthetics, abbv:OtherAesthetics


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value4223433183001420.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.02.62.32.31.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.02.62.32.31.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:OtherAesthetics100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:AlphaganCombigan


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value142118134123690.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.91.01.00.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.91.01.00.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:AlphaganCombigan100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:LumiganGanfort


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value149143153149760.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.11.11.20.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.11.11.20.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:LumiganGanfort100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:OtherEyeCare


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value3012762962691280.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.22.12.12.11.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.22.12.12.11.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:OtherEyeCare100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:Restasis


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value3272803442991440.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.32.22.52.31.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.32.22.52.31.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:Restasis100.0100.0100.0100.0100.00.0

abbv:HematologicOncology, abbv:Imbruvica


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value13811268142413701288123212961257109910221006972850762708688
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.99.710.310.612.414.314.914.813.313.112.111.810.39.69.19.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.99.710.310.612.414.314.914.813.313.112.111.810.39.69.19.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:HematologicOncology abbv:Imbruvica100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:HematologicOncology, abbv:VENCLEXTA


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value4354053653523033172512211691511249665594433
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.13.12.62.72.93.72.92.62.01.91.51.20.80.70.60.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.13.12.62.72.93.72.92.62.01.91.51.20.80.70.60.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:HematologicOncology abbv:VENCLEXTA100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:Immunology, abbv:HUMIRA


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value5068486751525140483747034917493648704446491851245185470948924701
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax36.337.437.239.846.454.656.558.259.056.859.262.262.659.463.267.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax36.337.437.239.846.454.656.558.259.056.859.262.262.659.463.267.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:HUMIRA100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:Immunology, abbv:RINVOQ


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value3783032812151498633140.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.72.32.01.71.41.00.40.20.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.72.32.01.71.41.00.40.20.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:RINVOQ100.0100.0100.0100.0100.0100.0100.0100.00.00.0

abbv:Immunology, abbv:SKYRIZI


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value67457452543533030021691480.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.84.43.83.43.23.52.51.10.60.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.84.43.83.43.23.52.51.10.60.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:SKYRIZI100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

abbv:Neuroscience, abbv:BotoxTherapeutic


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value6035325675232970.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.34.14.14.12.80.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.34.14.14.12.80.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:BotoxTherapeutic100.0100.0100.0100.0100.00.0

abbv:Neuroscience, abbv:Duodopa


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value127129129123118124118117115
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.91.00.91.01.11.41.41.41.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.91.00.91.01.11.41.41.41.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:Duodopa100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:Neuroscience, abbv:OtherNeuroscience


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value1711602272071050.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.21.61.61.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.21.61.61.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:OtherNeuroscience100.0100.0100.0100.0100.00.0

abbv:OtherKeyProducts, abbv:LinzessConstella


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value2682222862481330.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.91.72.11.91.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.91.72.11.91.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:LinzessConstella100.0100.0100.0100.0100.00.0

abbv:OtherKeyProducts, abbv:Lupron


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value198213181133205233219230209229236214223219224201
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.61.31.02.02.72.52.72.52.92.82.62.72.82.92.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.61.31.02.02.72.52.72.52.92.82.62.72.82.92.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:Lupron100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:OtherKeyProducts, abbv:MAVYRET


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value442415481414376559628695780
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.23.23.53.23.66.57.28.29.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.23.23.53.23.66.57.28.29.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:MAVYRET100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:WomensHealth, abbv:LoLoestrin


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value98104142134800.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.81.01.00.80.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.81.01.00.80.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:LoLoestrin100.0100.0100.0100.0100.00.0

abbv:WomensHealth, abbv:OrilissaOriahnn


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value383038253131342719
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.20.30.20.30.40.40.30.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.20.30.20.30.40.40.30.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:OrilissaOriahnn100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:WomensHealth, abbv:OtherWomensHealth


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value55467680360.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.40.50.60.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.40.50.60.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:OtherWomensHealth100.0100.0100.0100.0100.00.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax abbv:KeyProductPortfolio, us-gaap:ProductOrService, us-gaap:StatementGeographical

abbv:Aesthetics, abbv:BotoxCosmetic, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value3663053032371470.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.32.21.81.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.32.21.81.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:BotoxCosmetic country:US100.0100.0100.0100.0100.00.0

abbv:Aesthetics, abbv:BotoxCosmetic, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value218172190156790.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.31.41.20.80.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.31.41.20.80.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:BotoxCosmetic us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:Aesthetics, abbv:JuvedermCollection, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value196123147115560.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.40.91.10.90.50.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.40.91.10.90.50.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:JuvedermCollection country:US100.0100.0100.0100.0100.00.0

abbv:Aesthetics, abbv:JuvedermCollection, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value232198184159570.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.51.31.20.50.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.51.31.20.50.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:JuvedermCollection us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:Aesthetics, abbv:OtherAesthetics, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value3633002742651270.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.32.02.11.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.32.02.11.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:OtherAesthetics country:US100.0100.0100.0100.0100.00.0

abbv:Aesthetics, abbv:OtherAesthetics, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value59434435150.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.30.30.30.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.30.30.30.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Aesthetics abbv:OtherAesthetics us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:AlphaganCombigan, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value102809284470.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.60.70.70.50.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.60.70.70.50.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:AlphaganCombigan country:US100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:AlphaganCombigan, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value40384239220.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.30.30.30.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.30.30.30.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:AlphaganCombigan us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:LumiganGanfort, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value72666862350.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.50.50.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.50.50.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:LumiganGanfort country:US100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:LumiganGanfort, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value77778587410.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.60.70.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.60.70.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:LumiganGanfort us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:OtherEyeCare, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value130117132119540.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.91.00.90.50.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.91.00.90.50.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:OtherEyeCare country:US100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:OtherEyeCare, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value171159164150740.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.21.21.20.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.21.21.20.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:OtherEyeCare us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:Restasis, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value3122673332841380.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.22.12.42.21.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.22.12.42.21.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:Restasis country:US100.0100.0100.0100.0100.00.0

abbv:EyeCare, abbv:Restasis, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value151311156.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:EyeCare abbv:Restasis us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:HematologicOncology, abbv:Imbruvica, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value109999911651119105596610731042886829839812693624585574
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.97.78.48.710.111.212.312.310.710.610.19.98.47.97.68.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.97.78.48.710.111.212.312.310.710.610.19.98.47.97.68.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:HematologicOncology abbv:Imbruvica country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:HematologicOncology, abbv:VENCLEXTA, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value223225208204191201157142117105906947412925
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.71.51.61.82.31.81.71.41.31.10.80.60.50.40.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.71.51.61.82.31.81.71.41.31.10.80.60.50.40.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:HematologicOncology abbv:VENCLEXTA country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:HematologicOncology, abbv:VENCLEXTA, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value2121801571481121169479524634271818158.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.41.11.11.11.31.10.90.60.60.40.30.20.20.20.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.41.11.11.11.31.10.90.60.60.40.30.20.20.20.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:HematologicOncology abbv:VENCLEXTA us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:Immunology, abbv:HUMIRA, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value4257390742934189397436563969388737933215361535463521300333133151
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax30.530.031.032.538.142.445.645.845.941.143.543.142.537.842.845.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax30.530.031.032.538.142.445.645.845.941.143.543.142.537.842.845.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:HUMIRA country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:Immunology, abbv:HUMIRA, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value8119608599518631047948104910771231130315781664170615791550
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.87.46.27.48.312.110.912.413.015.715.719.220.121.520.422.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.87.46.27.48.312.110.912.413.015.715.719.220.121.520.422.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:HUMIRA us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:Immunology, abbv:RINVOQ, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value2962452441911368233140.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.11.91.81.51.31.00.40.20.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.11.91.81.51.31.00.40.20.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:RINVOQ country:US100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

abbv:Immunology, abbv:RINVOQ, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-06-302019-03-31
Value82583724134.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.40.30.20.10.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.40.30.20.10.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:RINVOQ us-gaap:NonUs100.0100.0100.0100.0100.0100.00.00.0

abbv:Immunology, abbv:SKYRIZI, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value56548145137928926619376420.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.03.73.32.92.83.12.20.90.50.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.03.73.32.92.83.12.20.90.50.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:SKYRIZI country:US100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

abbv:Immunology, abbv:SKYRIZI, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value109937456413423156.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.70.50.40.40.40.30.20.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.70.50.40.40.40.30.20.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Immunology abbv:SKYRIZI us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

abbv:Neuroscience, abbv:BotoxTherapeutic, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value4884294724292540.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.33.43.32.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.33.43.32.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:BotoxTherapeutic country:US100.0100.0100.0100.0100.00.0

abbv:Neuroscience, abbv:BotoxTherapeutic, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value1151039594430.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.80.70.70.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.80.70.70.40.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:BotoxTherapeutic us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:Neuroscience, abbv:Duodopa, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value252528252525252624
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.20.20.20.20.30.30.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.20.20.20.20.30.30.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:Duodopa country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:Neuroscience, abbv:Duodopa, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value102104101989399939191
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.80.70.80.91.11.11.11.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.80.70.80.91.11.11.11.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:Duodopa us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:Neuroscience, abbv:OtherNeuroscience, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value1671562222031030.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.21.61.61.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.21.61.61.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:OtherNeuroscience country:US100.0100.0100.0100.0100.00.0

abbv:Neuroscience, abbv:OtherNeuroscience, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value4.04.05.04.02.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:OtherNeuroscience us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:Neuroscience, abbv:Ubrelvy, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value126816538220.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.60.50.30.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.60.50.30.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:Ubrelvy country:US100.0100.0100.0100.0100.00.0

abbv:Neuroscience, abbv:Vraylar, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value4323464013581920.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.12.72.92.81.80.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.12.72.92.81.80.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:Neuroscience abbv:Vraylar country:US100.0100.0100.0100.0100.00.0

abbv:OtherKeyProducts, abbv:Creon, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value280274304282252276292265257227261239219209235215
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.02.12.22.22.43.23.43.13.12.93.12.92.62.63.03.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.02.12.22.22.43.23.43.13.12.93.12.92.62.63.03.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:Creon country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:OtherKeyProducts, abbv:LinzessConstella, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value2602152792401300.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.91.72.01.91.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.91.72.01.91.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:LinzessConstella country:US100.0100.0100.0100.0100.00.0

abbv:OtherKeyProducts, abbv:LinzessConstella, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value8.07.07.08.03.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:LinzessConstella us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:OtherKeyProducts, abbv:Lupron, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value15117113999167195174187168191196173180177181161
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.31.00.81.62.32.02.22.02.42.42.12.22.22.32.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.31.00.81.62.32.02.22.02.42.42.12.22.22.32.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:Lupron country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:OtherKeyProducts, abbv:Lupron, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value47424234383845434138404143424340
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.30.30.30.40.40.50.50.50.50.50.50.50.50.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.30.30.30.40.40.50.50.50.50.50.50.50.50.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:Lupron us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:OtherKeyProducts, abbv:MAVYRET, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value204170220185146234306368396
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.31.61.41.42.73.54.34.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.31.61.41.42.73.54.34.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:MAVYRET country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:OtherKeyProducts, abbv:MAVYRET, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value238245261229230325322327384
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.91.91.82.23.83.73.94.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.91.91.82.23.83.73.94.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:MAVYRET us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:OtherKeyProducts, abbv:Synthroid, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value192191194189183205204197203182209192193182205191
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.51.41.51.82.42.32.32.52.32.52.32.32.32.62.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.51.41.51.82.42.32.32.52.32.52.32.32.32.62.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherKeyProducts abbv:Synthroid country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:WomensHealth, abbv:LoLoestrin, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value93102139129780.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.81.01.00.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.81.01.00.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:LoLoestrin country:US100.0100.0100.0100.0100.00.0

abbv:WomensHealth, abbv:LoLoestrin, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value5.02.03.05.02.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:LoLoestrin us-gaap:NonUs100.0100.0100.0100.0100.00.0

abbv:WomensHealth, abbv:OrilissaOriahnn, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value362937243030332718
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.20.30.20.30.30.40.30.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.20.30.20.30.30.40.30.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:OrilissaOriahnn country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:WomensHealth, abbv:OrilissaOriahnn, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value2.01.01.01.01.01.01.00.01.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:OrilissaOriahnn us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.00.0100.0

abbv:WomensHealth, abbv:OtherWomensHealth, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value50467374340.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.40.50.60.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.40.50.60.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:OtherWomensHealth country:US100.0100.0100.0100.0100.00.0

abbv:WomensHealth, abbv:OtherWomensHealth, us-gaap:NonUs


Revenue
Period End2021-06-302020-12-312020-09-302020-06-302019-06-30
Value5.03.06.02.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:WomensHealth abbv:OtherWomensHealth us-gaap:NonUs100.0100.0100.0100.00.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService

abbv:OtherProducts


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value64089295182959010573832541146625151201187148289297271342309277302310308303486370393380628323395277571301336270
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.66.96.96.45.71.20.81.03.11.50.80.31.82.52.42.14.24.54.05.34.84.64.75.25.66.08.97.48.08.312.36.98.46.411.06.77.56.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.66.96.96.45.71.20.81.03.11.50.80.31.82.52.42.14.24.54.05.34.84.64.75.25.66.08.97.48.08.312.36.98.46.411.06.77.56.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abbv:OtherProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Revenues

us-gaap:Revenues

us-gaap:Revenues


Revenues
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value1395913010138581290210425861987048479825578288305823682787934773969956944653867966432645259586400594454755040545250194926456351114658469243295206450844934173
Percentage of Revenues100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Selling General And Administrative Expense

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:SellingGeneralAndAdministrativeExpense


Selling
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value31642842323128463527169519511657165416801929191917601791195114521504136816531381146613551737147417031473334115951448134014481261140612371411108512461247
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax22.721.823.322.133.819.722.419.520.021.523.223.321.322.625.220.821.720.924.321.522.722.727.124.831.129.261.331.829.429.428.327.130.028.627.124.127.729.9

Assets

us-gaap:Assets

us-gaap:Assets


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value147972150501150565149621149530911998911559441571425676959352661646164169342707866884066994656646609966626672115372053050548325385526699275472845429045286572919828252279102716927008
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:LiabilitiesAndStockholdersEquity


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value147972150501150565149621149530911998911559441571425676959352661646164169342707866884066994656646609966626672115372053050548325385526699275472845429045286572919828252279102716927008
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value1256913710130761527014708-7415.0-8172.0-8226.0-8566.0-7826.0-8446.0-2921.0-3375.0355350976687600949984636646956404643394548635504137717424645521846974492357735582957-350.0
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets8.59.18.710.29.8-8.1-9.2-13.8-15.0-13.8-14.2-4.4-5.55.17.29.79.07.67.09.78.48.67.48.910.25.26.316.318.016.415.412.712.710.9-1.3

Assets Current

us-gaap:AssetsCurrent

us-gaap:AssetsCurrent


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value2599926569241732300921256517584951920166151001441316945184651384520444212231893016962155471618716290167911662216314179121687715408160881755517794173291784816543156621492315354
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets17.617.716.115.414.256.855.633.926.425.428.627.922.529.530.027.525.323.724.524.425.030.930.832.731.357.758.461.761.360.561.158.656.154.956.8

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashAndCashEquivalentsAtCarryingValue


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312010-12-31
Value85469755844978906017411423992410648517248977289801535479007930384466088474051006218632775568399922374007906834877199086814095958975874369795901276174412710.0
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.86.55.65.34.045.144.817.99.18.612.312.15.813.013.112.39.17.27.79.39.414.115.816.813.729.630.327.131.328.432.931.831.325.721.80.00.00.00.00.0

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value854697558449789060174114239924106485172489772899303
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.86.55.65.34.045.144.817.99.18.612.313.1

Short Term Investments

us-gaap:ShortTermInvestments

us-gaap:ShortTermInvestments


Short
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value54223060230.00.024433177277019646748611081117150813231732167510448.02687918269.01160960300621115002075
Percentage of ShortTermInvestments100.0100.0100.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.40.61.31.20.30.70.71.61.72.32.02.62.51.90.00.01.60.10.10.04.03.31.02.20.01.87.7

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent

us-gaap:AccountsReceivableNetCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value99149588882284168354636254285529548256805384578057935841508848914859467747584999504847534730
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.76.45.95.65.67.06.19.39.610.09.18.79.48.47.27.17.37.17.27.57.58.88.9

us-gaap:AccountsReceivableNetCurrent us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:JanssenBiotechInc, us-gaap:CollaborativeArrangement


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302018-03-312017-12-31
Value308309283276258298235235230218177167153124
Percentage of AccountsReceivableNetCurrent3.13.23.23.33.14.74.34.34.23.83.32.92.62.4
Percentage of Assets0.20.20.20.20.20.30.30.40.40.40.30.30.20.2
Percentage of Assets abbv:JanssenBiotechInc us-gaap:CollaborativeArrangement0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Inventory Net

us-gaap:InventoryNet

us-gaap:InventoryNet


Inventory
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value33863272331034744059184418131929189517021605178615801738160517851582142714441630175617891719184116231022112410081048110411501172108510371091
Percentage of InventoryNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.32.22.22.32.72.02.03.23.33.02.72.72.62.52.32.62.42.22.22.42.63.33.23.43.03.84.13.53.63.93.94.13.93.84.0

Noncurrent Assets

us-gaap:NoncurrentAssets

us-gaap:NoncurrentAssets


Noncurrent
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value524829622883280326042600250023002200
Percentage of NoncurrentAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.53.34.94.03.94.99.17.98.1

us-gaap:NoncurrentAssets us-gaap:StatementGeographical

abbv:AllOtherCountries


Noncurrent
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value360290291320278184
Percentage of NoncurrentAssets6.99.810.111.410.77.1
Percentage of Assets0.20.30.50.50.40.3
Percentage of Assets abbv:AllOtherCountries0.00.00.00.00.00.0

abbv:UnitedStatesAndPuertoRico


Noncurrent
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value335420261993186218221900180016001600
Percentage of NoncurrentAssets63.968.469.166.470.073.172.069.672.7
Percentage of Assets2.22.33.42.62.83.66.55.55.9
Percentage of Assets abbv:UnitedStatesAndPuertoRico0.00.00.00.00.00.00.00.00.0

srt:Europe


Noncurrent
Period End2020-12-312019-12-312018-12-312017-12-31
Value1534646599621
Percentage of NoncurrentAssets29.221.820.822.2
Percentage of Assets1.00.71.00.9
Percentage of Assets srt:Europe0.00.00.00.0

Property Plant And Equipment Gross

us-gaap:PropertyPlantAndEquipmentGross

us-gaap:PropertyPlantAndEquipmentGross


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value1081610887108591039110327825081888492844383708396844982148231807178947786759675267710760174897334728171726988710570557147701669096790664665456542
Percentage of PropertyPlantAndEquipmentGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.37.27.26.96.99.09.214.314.814.714.112.813.311.911.411.511.611.611.411.611.313.913.813.313.326.225.824.824.624.523.724.023.824.124.2

us-gaap:PropertyPlantAndEquipmentGross us-gaap:PropertyPlantAndEquipmentByType

us-gaap:Building


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value255516131603142813441284122812631324
Percentage of PropertyPlantAndEquipmentGross23.519.719.117.717.917.517.318.320.2
Percentage of Assets1.71.82.72.02.02.44.54.34.9
Percentage of Assets us-gaap:Building0.00.00.00.00.00.00.00.00.0

us-gaap:ConstructionInProgress


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value1040491358604410348505382305
Percentage of PropertyPlantAndEquipmentGross9.66.04.37.55.44.77.15.54.7
Percentage of Assets0.70.60.60.90.60.71.81.31.1
Percentage of Assets us-gaap:ConstructionInProgress0.00.00.00.00.00.00.00.00.0

us-gaap:Equipment


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value697660126362599157265656532452144865
Percentage of PropertyPlantAndEquipmentGross64.273.475.874.276.177.174.975.574.4
Percentage of Assets4.66.710.78.58.710.719.317.918.0
Percentage of Assets us-gaap:Equipment0.00.00.00.00.00.00.00.00.0

us-gaap:Land


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value2887273484646485048
Percentage of PropertyPlantAndEquipmentGross2.70.90.90.60.60.60.70.70.7
Percentage of Assets0.20.10.10.10.10.10.20.20.2
Percentage of Assets us-gaap:Land0.00.00.00.00.00.00.00.00.0

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment


Accumulated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value56555694561154055419528952265598556455105513549954275403526851975129498449225072498348924769473546554557462046234760468346114546443343454295
Percentage of AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.83.83.73.63.65.85.99.49.79.79.38.38.87.87.47.57.77.67.47.67.49.19.08.68.617.116.816.216.416.315.816.115.916.015.9

Amortization Of Intangible Assets

us-gaap:AmortizationOfIntangibleAssets

us-gaap:AmortizationOfIntangibleAssets


Amortization
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value200020091838210014004443913893883853203203243302682682692712102081811651401258668969899110101137136135136134176179
Percentage of AmortizationOfIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AmortizationOfIntangibleAssets us-gaap:BusinessAcquisition

abbv:Allerganplc


Amortization
Period End2020-12-312020-09-302020-06-30
Value14001639961
Percentage of AmortizationOfIntangibleAssets76.278.068.6
Percentage of Assets0.00.00.0
Percentage of Assets abbv:Allerganplc0.00.00.0

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:PropertyPlantAndEquipmentNet


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value51615193524849864908296129622894287928602883295027872828280326972657261226042638261825972565254625172431248524322387233322982244221322002247
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.53.53.53.33.33.23.34.95.05.04.94.54.54.14.03.94.04.03.94.03.94.84.84.64.79.19.08.58.28.17.97.97.98.18.3

Long Term Investments

us-gaap:LongTermInvestments

us-gaap:LongTermInvestments


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value26630529324622578931311473147714201463150520572090197120522123178313781400387145741349392124130119118123121118119
Percentage of LongTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.20.20.20.20.10.10.22.62.62.42.22.43.03.02.93.13.22.72.12.10.70.30.10.20.30.30.40.40.40.40.40.40.40.4

Goodwill

us-gaap:Goodwill

us-gaap:Goodwill


Goodwill
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-05-262015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312011-12-31
Value32398323493312442801426691556115604155371564215606156631571815692158801578515748156521549015416156571550713274131681324313209761055345862600262446271627761996120606061306100
Percentage of Goodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets21.921.522.028.628.517.117.526.127.427.526.423.825.522.922.322.923.423.623.323.523.124.724.824.224.50.020.721.321.121.521.921.521.921.922.322.70.0

us-gaap:Goodwill us-gaap:BusinessAcquisition

abbv:Luminera


Goodwillus-gaap:
Period End2020-10-31
Value12
Percentage of Goodwill0.0
Percentage of Assets0.0
Percentage of Assets abbv:Luminera0.0

Indefinite Lived Intangible Assets Excluding Goodwill

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill


Indefinite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value155017271877104010400.00.010304920492099909990999099909990999099909990999010185393757375897579407445446446447447446446420420
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwill100.0100.0100.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.01.11.20.70.70.00.01.88.78.315.116.214.414.114.514.915.215.115.015.20.714.313.814.11.51.61.61.51.61.51.61.61.51.6

Intangible Assets Net Excluding Goodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill


Intangible
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value793408129382876746437646318203186491903620459208462123326625269032723027559281672836628629288972911329450195121970919822199371478151315401695180218901993210121532323
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets53.654.055.049.951.120.020.932.035.836.735.840.243.639.338.940.942.343.643.743.743.836.337.236.237.05.55.55.45.86.36.57.17.57.98.6

Finite Lived Intangible Assets Net

us-gaap:FiniteLivedIntangibleAssetsNet

us-gaap:FiniteLivedIntangibleAssetsNet


Finite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value777907956680999736037542318203186491903619429159261631316635169131724017569181771837618639189071912319265191191213612233123581071106810941249135514431547165517331903
Percentage of FiniteLivedIntangibleAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets52.652.953.849.250.420.020.932.034.028.127.525.127.424.924.826.427.428.428.628.728.735.622.922.322.94.03.93.84.34.74.95.55.96.47.0

us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:DevelopedTechnologyRights


Finite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value726187420776087685347019812851131421339213648100081025810483107041093411156116511183612020122081232612419122125159523253197848409281063114912411321142015181668
Percentage of FiniteLivedIntangibleAssetsNet93.493.393.993.193.170.670.570.470.262.862.963.063.363.463.564.164.464.564.664.564.563.942.542.843.073.278.784.885.184.886.085.485.887.687.7
Percentage of Assets49.149.350.545.846.914.114.722.523.917.617.315.817.415.815.816.917.718.318.518.518.522.79.79.59.92.93.03.33.74.04.34.75.15.66.2
Percentage of Assets us-gaap:DevelopedTechnologyRights0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:LicensingAgreements


Finite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value5172535949125069522553525507564457815918605561526209630664136526654066196699679768466907697770017039287228166186206202226235215235
Percentage of FiniteLivedIntangibleAssetsNet6.66.76.16.96.929.429.529.629.837.237.137.036.736.636.535.935.635.535.435.535.536.157.557.257.026.821.315.214.915.214.014.614.212.412.3
Percentage of Assets3.53.63.33.43.55.96.29.510.110.410.29.310.19.19.19.59.810.110.110.210.212.913.212.813.11.10.80.60.60.70.70.80.80.80.9
Percentage of Assets us-gaap:LicensingAgreements0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Operating Lease Right Of Use Asset

us-gaap:OperatingLeaseRightOfUseAsset us-gaap:BalanceSheetLocation

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OtherNoncurrentAssets


Operating
Period End2020-12-312019-12-31
Value895344
Percentage of OperatingLeaseRightOfUseAsset100.0100.0
Percentage of Assets0.60.4
Percentage of Assets us-gaap:OtherNoncurrentAssets0.00.0

Other Assets Noncurrent

us-gaap:OtherAssetsNoncurrent

us-gaap:OtherAssetsNoncurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value480847924851393640092638228816771589156712089439099031326132713051263121215501445132811491235118117551507801795803767115016931715835
Percentage of OtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.23.23.22.62.72.92.62.82.82.82.01.41.51.31.91.91.91.91.82.32.12.52.22.32.26.65.52.82.72.82.64.16.16.33.1

Equity Securities Fv Ni

us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:EquitySecuritiesFvNi

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-312018-12-31
Value11014714913895244.0
Percentage of EquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.10.10.10.10.00.0
Percentage of Assets us-gaap:FairValueInputsLevel1 us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-312018-12-31
Value1110.010.08.00.00.00.0
Percentage of EquitySecuritiesFvNi10.06.86.75.80.00.00.0
Percentage of Assets0.00.00.00.00.00.00.0
Percentage of Assets us-gaap:FairValueInputsLevel2 us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-312018-12-31
Value12115715914695244.0
Percentage of EquitySecuritiesFvNi110.0106.8106.7105.8100.0100.0100.0
Percentage of Assets0.10.10.10.10.10.00.0
Percentage of Assets us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.0

Accounts Payable And Accrued Liabilities Current

us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent

us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value20783206042015919404192751270911832122171130011826119311136610694106771022692128839841993799077875582398463804572516460695463126046619664486441637363305734
Percentage of AccountsPayableAndAccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets14.013.713.413.012.913.913.320.619.820.820.117.217.315.414.413.413.212.814.213.613.015.316.014.713.524.225.222.220.821.622.122.822.823.321.2

us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:JanssenBiotechInc, us-gaap:CollaborativeArrangement


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302018-03-312017-12-31
Value498460562468483445455467405373376310251253
Percentage of AccountsPayableAndAccruedLiabilitiesCurrent2.42.22.82.42.53.53.83.83.63.23.22.92.42.5
Percentage of Assets0.30.30.40.30.30.50.50.80.70.70.60.50.40.4
Percentage of Assets abbv:JanssenBiotechInc us-gaap:CollaborativeArrangement0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Accounts Payable Current

us-gaap:AccountsPayableCurrent

us-gaap:AccountsPayableCurrent


Accounts
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value227614521546147414071597881933556
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.51.62.62.12.13.03.23.22.1

Dividends Payable Current

us-gaap:DividendsPayableCurrent

us-gaap:DividendsPayableCurrent


Dividends
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value23351771160711431028924791643
Percentage of DividendsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.62.02.71.61.61.72.92.2

Liabilities Current

us-gaap:LiabilitiesCurrent

us-gaap:LiabilitiesCurrent


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value286843195128661241812464616471155851749316941139041723915387172241705816641130331225988449781910392721066210894881311258110501140066356317621668796875680567666776
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets19.421.219.016.216.518.117.529.429.624.529.023.327.924.623.518.918.313.514.813.713.819.820.516.120.941.441.423.321.721.723.624.324.424.925.1

Operating Lease Liability Current

us-gaap:OperatingLeaseLiabilityCurrent us-gaap:BalanceSheetLocation

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:AccountsPayableAndAccruedLiabilities


Operating
Period End2020-12-312019-12-31
Value175109
Percentage of OperatingLeaseLiabilityCurrent100.0100.0
Percentage of Assets0.10.1
Percentage of Assets us-gaap:AccountsPayableAndAccruedLiabilities0.00.0

Other Accrued Liabilities Current

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:OtherAccruedLiabilitiesCurrent


Other
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value620829713748326329792544191815311718
Percentage of OtherAccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.13.36.34.64.54.87.05.26.4

Long Term Debt

us-gaap:LongTermDebt

us-gaap:LongTermDebt


Long
Period End2020-12-31
Value84948
Percentage of LongTermDebt100.0
Percentage of Assets56.4

us-gaap:LongTermDebt us-gaap:DebtInstrument

abbv:AllerganSeniorNotesAcquired


Long
Period End2020-09-302020-06-30
Value2042620960
Percentage of LongTermDebt0.00.0
Percentage of Assets13.714.0
Percentage of Assets abbv:AllerganSeniorNotesAcquired0.00.0

us-gaap:LongTermDebt us-gaap:DebtInstrument, us-gaap:LongtermDebtType

abbv:SeniorEuroNotesDue2020AtFloatingRates, us-gaap:SeniorNotes


Long
Period End2020-09-302020-06-30
Value821788
Percentage of LongTermDebt0.00.0
Percentage of Assets0.50.5
Percentage of Assets abbv:SeniorEuroNotesDue2020AtFloatingRates us-gaap:SeniorNotes0.00.0

abbv:SeniorEuroNotesDue2021At0.500Percent, us-gaap:SeniorNotes


Long
Period End2020-09-302020-06-30
Value879845
Percentage of LongTermDebt0.00.0
Percentage of Assets0.60.6
Percentage of Assets abbv:SeniorEuroNotesDue2021At0.500Percent us-gaap:SeniorNotes0.00.0

abbv:SeniorEuroNotesDue2023At1.500Percent, us-gaap:SeniorNotes


Long
Period End2020-09-302020-06-30
Value586563
Percentage of LongTermDebt0.00.0
Percentage of Assets0.40.4
Percentage of Assets abbv:SeniorEuroNotesDue2023At1.500Percent us-gaap:SeniorNotes0.00.0

abbv:SeniorEuroNotesDue2024At1.250Percent, us-gaap:SeniorNotes


Long
Period End2020-09-302020-06-30
Value821788
Percentage of LongTermDebt0.00.0
Percentage of Assets0.50.5
Percentage of Assets abbv:SeniorEuroNotesDue2024At1.250Percent us-gaap:SeniorNotes0.00.0

abbv:SeniorEuroNotesDue2028At2.625Percent, us-gaap:SeniorNotes


Long
Period End2020-09-302020-06-30
Value586563
Percentage of LongTermDebt0.00.0
Percentage of Assets0.40.4
Percentage of Assets abbv:SeniorEuroNotesDue2028At2.625Percent us-gaap:SeniorNotes0.00.0

abbv:SeniorEuroNotesDue2029At2.125Percent, us-gaap:SeniorNotes


Long
Period End2020-09-302020-06-30
Value645619
Percentage of LongTermDebt0.00.0
Percentage of Assets0.40.4
Percentage of Assets abbv:SeniorEuroNotesDue2029At2.125Percent us-gaap:SeniorNotes0.00.0

Debt And Capital Lease Obligations

us-gaap:DebtAndCapitalLeaseObligations

us-gaap:DebtAndCapitalLeaseObligations


Debt
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value860226672836611369683646531265145861431014652
Percentage of DebtAndCapitalLeaseObligations100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets57.174.961.752.255.258.952.949.054.3

us-gaap:DebtAndCapitalLeaseObligations us-gaap:DebtInstrument, us-gaap:LongtermDebtType

abbv:FloatingRateTermLoanTrancheDueMay2023, us-gaap:LoansPayable


Debt
Period End2020-12-31
Value1000
Percentage of DebtAndCapitalLeaseObligations1.2
Percentage of Assets0.7
Percentage of Assets abbv:FloatingRateTermLoanTrancheDueMay2023 us-gaap:LoansPayable0.0

abbv:FloatingRateTermLoanTrancheDueMay2025, us-gaap:LoansPayable


Debt
Period End2020-12-31
Value2000
Percentage of DebtAndCapitalLeaseObligations2.3
Percentage of Assets1.3
Percentage of Assets abbv:FloatingRateTermLoanTrancheDueMay2025 us-gaap:LoansPayable0.0

abbv:SeniorNotesIssuedin2015, us-gaap:SeniorNotes


Debt
Period End2020-12-312019-12-31
Value1000013700
Percentage of DebtAndCapitalLeaseObligations11.620.5
Percentage of Assets6.615.4
Percentage of Assets abbv:SeniorNotesIssuedin2015 us-gaap:SeniorNotes0.00.0

Long Term Debt And Capital Lease Obligations

us-gaap:LongTermDebtAndCapitalLeaseObligations

us-gaap:LongTermDebtAndCapitalLeaseObligations


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value7423774183775548228282061632846297533126316193506635002364873057930906309533397433817365263644037284373282949029240313592711610683105651446914470143861429214375143261460114630
Percentage of LongTermDebtAndCapitalLeaseObligations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets50.249.351.555.054.969.470.755.755.361.859.055.149.644.643.749.450.555.655.156.055.554.955.157.250.440.038.450.949.850.248.950.951.353.754.2

Deferred Income Tax Liabilities Net

us-gaap:DeferredIncomeTaxLiabilitiesNet

us-gaap:DeferredIncomeTaxLiabilitiesNet


Deferred
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value366137683646448547859591130
Percentage of DeferredIncomeTaxLiabilitiesNet100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.52.52.43.03.21.11.3

Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent

us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent

us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent


Pension
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value34132949184027402085194922201628979
Percentage of PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.33.33.13.93.23.78.15.63.6

us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Pension
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value7721032546798613
Percentage of PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent22.635.029.729.129.4
Percentage of Assets0.51.20.91.10.9
Percentage of Assets us-gaap:OtherPostretirementBenefitPlansDefinedBenefit0.00.00.00.00.0

us-gaap:PensionPlansDefinedBenefit


Pension
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value26411917129419421472
Percentage of PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent77.465.070.370.970.6
Percentage of Assets1.82.22.22.72.2
Percentage of Assets us-gaap:PensionPlansDefinedBenefit0.00.00.00.00.0

Minority Interest

us-gaap:MinorityInterest

us-gaap:MinorityInterest


Minority
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-31
Value25232119240.0
Percentage of MinorityInterest100.0100.0100.0100.0100.00.0
Percentage of Assets0.00.00.00.00.00.0

Other Liabilities Noncurrent

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OtherLiabilitiesNoncurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value28796268662760723384233061790012221307124111608449901337900
Percentage of OtherLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets19.517.918.315.615.619.61.42.21.81.81.63.64.63.3

Operating Lease Liability Noncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent us-gaap:BalanceSheetLocation

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OtherNoncurrentLiabilities


Operating
Period End2020-12-312019-12-31
Value832251
Percentage of OperatingLeaseLiabilityNoncurrent100.0100.0
Percentage of Assets0.60.3
Percentage of Assets us-gaap:OtherNoncurrentLiabilities0.00.0

Lessee Operating Lease Liability Payments Due Year Two

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo


Lessee
Period End2020-12-31
Value178
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearTwo100.0
Percentage of Assets0.1

Lessee Operating Lease Liability Payments Due Year Three

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree


Lessee
Period End2020-12-31
Value140
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearThree100.0
Percentage of Assets0.1

Lessee Operating Lease Liability Payments Due Year Four

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour


Lessee
Period End2020-12-31
Value111
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFour100.0
Percentage of Assets0.1

Lessee Operating Lease Liability Payments Due Year Five

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive


Lessee
Period End2020-12-31
Value96
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFive100.0
Percentage of Assets0.1

Lessee Operating Lease Liability Payments Due After Year Five

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive


Lessee
Period End2020-12-31
Value394
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive100.0
Percentage of Assets0.3

Operating Lease Liability

us-gaap:OperatingLeaseLiability

us-gaap:OperatingLeaseLiability


Operating
Period End2020-12-31
Value1007
Percentage of OperatingLeaseLiability100.0
Percentage of Assets0.7

Lessee Operating Lease Liability Payments Due

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue


Lessee
Period End2020-12-31
Value1121
Percentage of LesseeOperatingLeaseLiabilityPaymentsDue100.0
Percentage of Assets0.7

Lessee Operating Lease Liability Undiscounted Excess Amount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount


Lessee
Period End2020-12-31
Value114
Percentage of LesseeOperatingLeaseLiabilityUndiscountedExcessAmount100.0
Percentage of Assets0.1

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value1256913710130761527014708-7415.0-8172.0-8226.0-8566.0-7826.0-8446.0-2921.0-3375.0355350976687600949984636646956404643394548635504137717424645521846974492357735582957-350.0
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets8.59.18.710.29.8-8.1-9.2-13.8-15.0-13.8-14.2-4.4-5.55.17.29.79.07.67.09.78.48.67.48.910.25.26.316.318.016.415.412.712.710.9-1.3

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value1259413733130971528914732-7415.0-8172.0-8226.0-8566.0-7826.0-8446.05097
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets8.59.18.710.29.9-8.1-9.2-13.8-15.0-13.8-14.27.2

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents

abbv:AccumulatedNetGainLossFromNetInvestmentHedges


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value-530.0-416.0-790.0-446.0-132.0819.0119-37.0-65.0-203.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-4.2-3.0-6.0-2.9-0.9-1.1-0.1-1.40.40.8-4.0
Percentage of Assets-0.4-0.3-0.5-0.3-0.10.10.00.2-0.1-0.1-0.3
Percentage of Assets abbv:AccumulatedNetGainLossFromNetInvestmentHedges0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value-2938.0-2988.0-3067.0-2831.0-2866.0-2909.0-2965.0-1644.0-1677.0-1722.0-1919.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-23.3-21.8-23.4-18.5-19.539.236.320.019.620.4-37.6
Percentage of Assets-2.0-2.0-2.0-1.9-1.9-3.2-3.3-2.8-2.9-2.9-2.7
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value150-94.0583-202.0-714.0-1155.0-928.0-1118.0-862.0-830.0-439.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest1.2-0.74.5-1.3-4.815.611.413.610.19.8-8.6
Percentage of Assets0.1-0.10.4-0.1-0.5-1.3-1.0-1.9-1.5-1.4-0.6
Percentage of Assets us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value21520315722027728628811584147-166.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest1.71.51.21.41.9-3.9-3.5-1.4-1.0-1.7-3.3
Percentage of Assets0.10.10.10.10.20.30.30.20.10.2-0.2
Percentage of Assets us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value-3103.0-3295.0-3117.0-3259.0-3435.0-3697.0-3596.0-2528.0-2491.0-2516.0-2480.0-2727.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-24.6-24.0-23.8-21.3-23.349.944.030.729.132.129.4-53.5
Percentage of Assets-2.1-2.2-2.1-2.2-2.3-4.1-4.0-4.3-4.4-4.4-4.2-3.9
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value179361771217384171481695315401151931511215028149401475614270
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest142.4129.0132.7112.2115.1-207.7-185.9-183.7-175.4-190.9-174.7280.0
Percentage of Assets12.111.811.511.511.316.917.025.426.326.324.920.2
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value-3103.0-3295.0-3117.0-3259.0-3435.0-3697.0-3596.0-2528.0-2491.0-2480.0-2727.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-24.6-24.0-23.8-21.3-23.349.944.030.729.129.4-53.5
Percentage of Assets-2.1-2.2-2.1-2.2-2.3-4.1-4.0-4.3-4.4-4.2-3.9
Percentage of Assets us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-06-302019-03-312018-12-31
Value25232119240.00.00.00.00.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.20.20.20.10.2-0.0-0.0-0.0-0.0-0.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value74022921055333531305973471736733384423433685459
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest5.916.78.121.821.2-80.6-57.7-44.7-39.5-54.1-39.9107.1
Percentage of Assets0.51.50.72.22.16.55.36.25.97.55.77.7
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:TreasuryStock


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value-3022.0-3017.0-2264.0-1972.0-1958.0-25110.0-24504.0-24501.0-24505.0-24502.0-24108.0-11923.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-24.0-22.0-17.3-12.9-13.3338.6299.9297.8286.1313.1285.4-233.9
Percentage of Assets-2.0-2.0-1.5-1.3-1.3-27.5-27.5-41.2-42.9-43.2-40.6-16.8
Percentage of Assets us-gaap:TreasuryStock0.00.00.00.00.00.00.00.00.00.00.00.0

Additional Paid In Capital Common Stock

us-gaap:AdditionalPaidInCapitalCommonStock

us-gaap:AdditionalPaidInCapitalCommonStock


Additional
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value17936177121738417148169531540115193151121502814940147561468014596145191427014154140151388913678135401304613293130801300512421440341944083399639053671
Percentage of AdditionalPaidInCapitalCommonStock100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets12.111.811.511.511.316.917.025.426.326.324.922.223.720.920.220.620.921.220.720.319.424.724.723.723.116.515.214.313.813.612.6

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:RetainedEarningsAccumulatedDeficit


Retained
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value7402292105533353130597347173673338442343368678954954977545965475951506343784011334926732248165412567395352131229918741567
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.51.50.72.22.16.55.36.25.97.55.710.38.97.27.79.58.97.76.66.05.05.04.23.02.32.81.97.57.96.55.4

Accumulated Other Comprehensive Income Loss Net Of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax


Accumulated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312011-12-312010-12-31
Value-3103.0-3295.0-3117.0-3259.0-3435.0-3697.0-3596.0-2528.0-2491.0-2516.0-2480.0-2559.0-2639.0-2630.0-2727.0-2613.0-2548.0-2542.0-2586.0-2340.0-2390.0-2423.0-2561.0-2499.0-2374.0-2467.0-2031.0-913.0-420.0-426.0-442.0-981.0-1169.0-1237.0-350.0-25.0288
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-2.1-2.2-2.1-2.2-2.3-4.1-4.0-4.3-4.4-4.4-4.2-3.9-4.3-3.8-3.9-3.8-3.8-3.9-3.9-3.5-3.6-4.5-4.8-4.6-4.4-9.2-7.4-3.2-1.4-1.5-1.5-3.5-4.2-4.6-1.30.00.0

Treasury Stock Value

us-gaap:TreasuryStockValue

us-gaap:TreasuryStockValue


Treasury
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value3022301722641972195825110245042450124505245022410821849208451333111923114191142711430108528760838389188839731458161314972672673672320
Percentage of TreasuryStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.02.01.51.31.327.527.541.242.943.240.633.033.819.216.816.617.117.416.413.112.516.616.713.310.84.93.52.42.32.31.1

Minority Interest

us-gaap:MinorityInterest

us-gaap:MinorityInterest


Minority
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-31
Value25232119240.0
Percentage of MinorityInterest100.0100.0100.0100.0100.00.0
Percentage of Assets0.00.00.00.00.00.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value489048774854583030893815327545552477301733924524286626452584327120032102145419182128
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax35.037.535.045.229.644.337.653.730.038.540.854.934.633.333.446.828.832.222.629.735.7

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value-242.0-342.0-627.0-1149.0-35652.0-129.0-615.01378-140.0-27.0-283.0-963.0687-447.0201-109.0318-684.0-199.0-4298.0-1458.0
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-1.7-2.6-4.5-8.9-342.0-1.5-7.116.3-1.7-0.3-3.4-11.78.3-5.62.6-1.64.6-10.5-3.1-66.6-24.5

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-5884.0-3174.0-3695.0-2814.0-2570.0-2422.026602-441.0-2070.0-5383.0-3825.0916-8978.0-2509.0-1928.0-810.0-980.0-1794.0-2502.0-1371.01164-1219.0
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-42.2-24.4-26.7-21.8-24.7-28.1305.6-5.2-25.1-68.8-46.111.1-108.5-31.6-24.9-11.6-14.1-27.4-36.8-21.318.0-20.5

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value-1209.013065591873-35125.01218292765476275-2392.0
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-8.710.04.014.5-336.914.1336.464.63.3-30.6

Deferred Income Tax Expense Benefit

us-gaap:DeferredIncomeTaxExpenseBenefit

us-gaap:DeferredIncomeTaxExpenseBenefit


Deferred
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-91.0-28.0-1827.0-241.0-76.0-181.0199-149.0
Percentage of DeferredIncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Accounts Receivable

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInAccountsReceivable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value29686635531-482.01025-133.0111-220.0316-215.01.0124681228-4.013334-58.0-65.0275-81.023425444544
Percentage of IncreaseDecreaseInAccountsReceivable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Inventories

us-gaap:IncreaseDecreaseInInventories

us-gaap:IncreaseDecreaseInInventories


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value62187-153.0-111.0197107-170.0113160128-141.017612071-212.012070-71.066-28.019-19.0-12.0286857522377-47.0-50.0-30.03661-11.010443497.0
Percentage of IncreaseDecreaseInInventories100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value489048774854583030893815327545552477301733924524286626452584327120032102145419182128
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax35.037.535.045.229.644.337.653.730.038.540.854.934.633.333.446.828.832.222.629.735.7

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value7663553362308-738.03010280118847412456-1826.02747198327835216311915171113911598161013541517123913661022
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.527.30.317.9-7.134.932.222.29.031.4-22.033.424.035.10.723.327.626.220.524.825.022.723.720.824.920.3

us-gaap:NetIncomeLoss us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:NetInvestmentHedging, us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value4.03.02.02.04.06.06.08.07.00.00.00.00.0
Percentage of NetIncomeLoss0.50.15.60.1-0.50.20.20.40.90.0-0.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.10.10.10.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NetInvestmentHedging us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParent0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NetIncomeLoss us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-20.0-11.04.010.03.06.0483935
Percentage of NetIncomeLoss-2.6-0.311.10.4-0.40.21.72.14.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.10.00.10.00.10.60.50.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest0.00.00.00.00.00.00.00.00.0

us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value7663553362308-738.03010280118847412456-1826.0274719832783
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.527.30.317.9-7.134.932.222.29.031.4-22.033.424.035.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Profit Loss

us-gaap:ProfitLoss

us-gaap:ProfitLoss


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value7693555382313-739.0301028011884741
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.527.30.317.9-7.134.932.222.29.0

Share Based Compensation

us-gaap:ShareBasedCompensation

us-gaap:ShareBasedCompensation


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value1592691361622362197975871897075851917771761417569711385355551194344481063742468731303591
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value-242.0-342.0-627.0-1149.0-35652.0-129.0-615.01378-140.0-27.0-283.0-963.0687-447.0201-109.0318-684.0-199.0-4298.0-1458.0
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-1.7-2.6-4.5-8.9-342.0-1.5-7.116.3-1.7-0.3-3.4-11.78.3-5.62.6-1.64.6-10.5-3.1-66.6-24.5

Payments To Acquire Property Plant And Equipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value195188279217177125163154128107123282114119182126126951141131311211451271151451531801421371511331198895-18.094162
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-5884.0-3174.0-3695.0-2814.0-2570.0-2422.026602-441.0-2070.0-5383.0-3825.0916-8978.0-2509.0-1928.0-810.0-980.0-1794.0-2502.0-1371.01164-1219.0
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-42.2-24.4-26.7-21.8-24.7-28.1305.6-5.2-25.1-68.8-46.111.1-108.5-31.6-24.9-11.6-14.1-27.4-36.8-21.318.0-20.5

Proceeds From Issuance Of Long Term Debt

us-gaap:ProceedsFromIssuanceOfLongTermDebt

us-gaap:ProceedsFromIssuanceOfLongTermDebt


Proceeds
Period End2020-12-312020-09-302019-12-312018-12-312017-12-312017-09-302016-12-312016-09-302015-12-312015-09-30
Value0.00.0299480.00.00.038560.040005.0
Percentage of ProceedsFromIssuanceOfLongTermDebt0.00.0100.00.00.00.0100.00.0100.0100.0

Payments Of Dividends

us-gaap:PaymentsOfDividends

us-gaap:PaymentsOfDividends


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value231023222101210017521763159515911592158814511461153111371030102610241027933933927924840850818786674673673641641640638636
Percentage of PaymentsOfDividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Payments For Repurchase Of Common Stock

us-gaap:PaymentsForRepurchaseOfCommonStock

us-gaap:PaymentsForRepurchaseOfCommonStock


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value10.078729620196432.04.03.062020581009751614315055.05.08951824-3.0380340912259985002342300-1.024329201-2.02497
Percentage of PaymentsForRepurchaseOfCommonStock100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Effective Income Tax Rate Continuing Operations

us-gaap:EffectiveIncomeTaxRateContinuingOperations

us-gaap:EffectiveIncomeTaxRateContinuingOperations


Effective
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value14.08.0-36.077.0-0.070.030.0150.060.080.03-0.1040.010.020.010.1130.220.190.180.0250.210.230.24-0.0040.250.190.270.010.2630.2340.238-0.0030.250.2190.2190.0090.0120.0960.122
Percentage of EffectiveIncomeTaxRateContinuingOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

us-gaap:EmployeeStockOption


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value156.7616.1438.31615181921232425272830323335
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:EmployeeStockOption


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value73.960.3955.0541.6933.6332.4832.4832.9830.6430.430.2530.1928.5328.2728.2328.127.48
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

abbv:RestrictedStockUnitsAndPerformanceShares


Share
Period End2021-06-302021-03-312020-12-31
Value1000000.06300000.024000.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod100.0100.0100.0

Deferred Tax Liabilities

us-gaap:DeferredTaxLiabilities

us-gaap:DeferredTaxLiabilities


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value1232615739222266655048
Percentage of DeferredTaxLiabilities100.0100.0100.0100.0100.0100.0

Deferred Tax Assets Net

us-gaap:DeferredTaxAssetsNet

us-gaap:DeferredTaxAssetsNet


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value535927862662192420772369198015371537
Percentage of DeferredTaxAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0

Unrecognized Tax Benefits

us-gaap:UnrecognizedTaxBenefits

us-gaap:UnrecognizedTaxBenefits


Unrecognized
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Value52642661285227011168954421247114010391645
Percentage of UnrecognizedTaxBenefits100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Assets Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance

us-gaap:DeferredTaxAssetsValuationAllowance


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value12037311031087670172437.0
Percentage of DeferredTaxAssetsValuationAllowance100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:AdditionalContributionToCollaboration us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:TypeOfArrangement

abbv:AdditionalContributionToCollaboration

abbv:CalicoLifeSciencesLLC, srt:ScenarioForecast, us-gaap:CollaborativeArrangement


Additional
Period End2021-09-30
Value500
Percentage of AdditionalContributionToCollaboration100.0

abbv:AdditionalContributionToCollaborationByPartner us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:TypeOfArrangement

abbv:AdditionalContributionToCollaborationByPartner

abbv:CalicoLifeSciencesLLC, srt:ScenarioForecast, us-gaap:CollaborativeArrangement


Additional
Period End2021-09-30
Value500
Percentage of AdditionalContributionToCollaborationByPartner100.0

abbv:AmortizationofInventoryFairValueStepup us-gaap:BusinessAcquisition

abbv:AmortizationofInventoryFairValueStepup

abbv:Allerganplc


Amortizationof
Period End2020-12-31
Value236
Percentage of AmortizationofInventoryFairValueStepup100.0

abbv:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNet us-gaap:BusinessAcquisition

abbv:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNet

abbv:Allerganplc


Business
Period End2021-06-302021-03-31
Value0.02.0
Percentage of BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNet0.0100.0

abbv:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsDeferredIncomeTaxLiabilities us-gaap:BusinessAcquisition

abbv:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsDeferredIncomeTaxLiabilities

abbv:Allerganplc


Business
Period End2021-06-302021-03-31
Value0.0148
Percentage of BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsDeferredIncomeTaxLiabilities0.0100.0

abbv:CollaborativeArrangementsPercentageOfShareOfDevelopmentCosts us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:CollaborativeArrangementsPercentageOfShareOfDevelopmentCosts

abbv:JanssenBiotechInc, us-gaap:CollaborativeArrangement


Collaborative
Period End2021-06-302021-03-31
Value040.0
Percentage of CollaborativeArrangementsPercentageOfShareOfDevelopmentCosts0.0100.0

abbv:CollaborativeArrangementsPercentageOfShareOfDevelopmentCostsResponsibleByThirdParty us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:CollaborativeArrangementsPercentageOfShareOfDevelopmentCostsResponsibleByThirdParty

abbv:JanssenBiotechInc, us-gaap:CollaborativeArrangement


Collaborative
Period End2021-06-302021-03-312020-12-31
Value060.00
Percentage of CollaborativeArrangementsPercentageOfShareOfDevelopmentCostsResponsibleByThirdParty0.0100.00.0

abbv:CostofGoodsAndServicesSoldFromCollaborativeArrangements us-gaap:CounterpartyName, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

abbv:CostofGoodsAndServicesSoldFromCollaborativeArrangements

abbv:JanssenBiotechInc, country:US, us-gaap:CollaborativeArrangement


Costof
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value514465545524493450506489422
Percentage of CostofGoodsAndServicesSoldFromCollaborativeArrangements100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:CostofGoodsAndServicesSoldFromCollaborativeArrangements us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:GenentechInc., us-gaap:CollaborativeArrangement


Costof
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value1681591431391231281008969
Percentage of CostofGoodsAndServicesSoldFromCollaborativeArrangements32.734.226.226.524.928.419.818.216.4

abbv:DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit us-gaap:RetirementPlanType

abbv:DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-8000000.0-8000000.0-7000000.0-4000000.0-6000000.00-1000000.0-1000000.01000000.0003000000.0-4000000.01000000.0-1000000.0
Percentage of DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit100.0100.0100.0100.0100.00.0100.0100.0100.00.00.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-75000000.0-70000000.0-57000000.0-59000000.0-55000000.0-27000000.0-27000000.0-29000000.0-26000000.0-26000000.0-38000000.0-39000000.0-37000000.0-27000000.0-27000000.0
Percentage of DefinedBenefitPlanAmortizationOfActuarialGainLossPriorServiceCostCredit937.5875.0814.31475.0916.70.02700.02900.0-2600.00.00.0-1300.0925.0-2700.02700.0

abbv:EffectiveIncomeTaxRateReconciliationTaxLawChangesAmount

abbv:EffectiveIncomeTaxRateReconciliationTaxLawChangesAmount


Effective
Period End2020-12-31
Value-1500000000.0
Percentage of EffectiveIncomeTaxRateReconciliationTaxLawChangesAmount100.0

abbv:EffectonFutureEarningsPercent us-gaap:IncomeStatementLocation, us-gaap:RestructuringPlan

abbv:EffectonFutureEarningsPercent

us-gaap:CostOfSales, abbv:AllerganIntegrationPlan


Effecton
Period End2020-09-30
Value9.9
Percentage of EffectonFutureEarningsPercent100.0

us-gaap:ResearchAndDevelopmentExpense, abbv:AllerganIntegrationPlan


Effecton
Period End2020-09-30
Value49.5
Percentage of EffectonFutureEarningsPercent500.0

us-gaap:SellingGeneralAndAdministrativeExpenses, abbv:AllerganIntegrationPlan


Effecton
Period End2020-09-30
Value39.6
Percentage of EffectonFutureEarningsPercent400.0

abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax

abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-114.0374-344.0-314.0-213.072-110.0156-37.0
Percentage of OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeTax

abbv:OtherComprehensiveIncomeLossNetInvestmentHedgeTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-31.0103-96.0-85.0-60.020-31.045-11.0
Percentage of OtherComprehensiveIncomeLossNetInvestmentHedgeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:OtherExpensesFromCollaborativeArrangements us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:OtherExpensesFromCollaborativeArrangements

abbv:JanssenBiotechInc, us-gaap:CollaborativeArrangement


Other
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-30
Value74707467708177
Percentage of OtherExpensesFromCollaborativeArrangements100.0100.0100.0100.0100.0100.0100.0

abbv:ResearchAndDevelopmentExpenseFromCollaborativeArrangements us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:ResearchAndDevelopmentExpenseFromCollaborativeArrangements

abbv:GenentechInc., us-gaap:CollaborativeArrangement


Research
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value344241273625343230
Percentage of ResearchAndDevelopmentExpenseFromCollaborativeArrangements100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:ResearchandDevelopmentAssetAcquiredOtherthanThroughBusinessCombinationWrittenoffMilestonePayment us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement

abbv:ResearchandDevelopmentAssetAcquiredOtherthanThroughBusinessCombinationWrittenoffMilestonePayment

abbv:IMabBiopharma, srt:ScenarioForecast, us-gaap:InProcessResearchAndDevelopment, us-gaap:CollaborativeArrangement


Researchand
Period End2020-12-31
Value20
Percentage of ResearchandDevelopmentAssetAcquiredOtherthanThroughBusinessCombinationWrittenoffMilestonePayment100.0

abbv:ResearchandDevelopmentAssetAcquiredOtherthanThroughBusinessCombinationWrittenoffUpfrontPayment us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement

abbv:ResearchandDevelopmentAssetAcquiredOtherthanThroughBusinessCombinationWrittenoffUpfrontPayment

abbv:IMabBiopharma, srt:ScenarioForecast, us-gaap:InProcessResearchAndDevelopment, us-gaap:CollaborativeArrangement


Researchand
Period End2020-12-31
Value180
Percentage of ResearchandDevelopmentAssetAcquiredOtherthanThroughBusinessCombinationWrittenoffUpfrontPayment100.0

abbv:RestructuringReserveCashSettledRestructuringGainsLosses us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan

abbv:RestructuringReserveCashSettledRestructuringGainsLosses

us-gaap:EmployeeSeverance, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value10.02112773394
Percentage of RestructuringReserveCashSettledRestructuringGainsLosses100.0100.0100.0100.0100.0

us-gaap:OtherRestructuring, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value108108132160105
Percentage of RestructuringReserveCashSettledRestructuringGainsLosses1080.0514.3103.9219.226.6

abbv:RestructuringReserveCashSettledRestructuringGainsLosses us-gaap:RestructuringPlan

abbv:OtherRestructuringPlans


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-30
Value5.0381811
Percentage of RestructuringReserveCashSettledRestructuringGainsLosses50.0181.014.215.1

abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan

abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments

us-gaap:EmployeeSeverance, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value113464913246
Percentage of RestructuringReservePeriodCashSettledAndOtherAdjustments100.0100.0100.0100.0100.0

us-gaap:OtherRestructuring, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value12010214513498
Percentage of RestructuringReservePeriodCashSettledAndOtherAdjustments106.2221.7295.9101.5213.0

abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments us-gaap:RestructuringPlan

abbv:OtherRestructuringPlans


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-30
Value28362120
Percentage of RestructuringReservePeriodCashSettledAndOtherAdjustments24.878.342.915.2

abbv:SellingGeneralAndAdministrativeExpenseFromCollaborativeArrangements us-gaap:CounterpartyName, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

abbv:SellingGeneralAndAdministrativeExpenseFromCollaborativeArrangements

abbv:GenentechInc., country:US, us-gaap:CollaborativeArrangement


Selling
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value8.011129.01114149.010.0
Percentage of SellingGeneralAndAdministrativeExpenseFromCollaborativeArrangements100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:UpfrontCostsRelatedToCollaborations

abbv:UpfrontCostsRelatedToCollaborations


Upfront
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-31
Value132185348859034014920126195350555551013853225285080125250.01302312752855848
Percentage of UpfrontCostsRelatedToCollaborations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0

us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax

us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax


Allocated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value1332211141301981806360711565862661628951589454349590
Percentage of AllocatedShareBasedCompensationExpenseNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss us-gaap:BusinessAcquisition

us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss

abbv:Allerganplc


Business
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-30
Value6042829532577977-1735.0
Percentage of BusinessAcquisitionsProFormaNetIncomeLoss100.0100.0100.0100.0100.0100.0

us-gaap:BusinessAcquisitionsProFormaRevenue us-gaap:BusinessAcquisition

us-gaap:BusinessAcquisitionsProFormaRevenue

abbv:Allerganplc


Business
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-30
Value138581290211542129431242812267
Percentage of BusinessAcquisitionsProFormaRevenue100.0100.0100.0100.0100.0100.0

us-gaap:BusinessCombinationAcquisitionRelatedCosts us-gaap:BusinessAcquisition, us-gaap:IncomeStatementLocation

us-gaap:BusinessCombinationAcquisitionRelatedCosts

abbv:Allerganplc, us-gaap:SellingGeneralAndAdministrativeExpenses


Business
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-30
Value0.00.0777532624
Percentage of BusinessCombinationAcquisitionRelatedCosts0.00.0100.0100.0100.0100.0

us-gaap:BusinessCombinationConsiderationTransferred1 us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationConsiderationTransferred1

abbv:Luminera


Business
Period End2020-10-31
Value186
Percentage of BusinessCombinationConsiderationTransferred1100.0

us-gaap:BusinessCombinationConsiderationTransferred1 us-gaap:StatementScenario, us-gaap:BusinessAcquisition

srt:ScenarioForecast, abbv:SolitonInc


Business
Period End2021-08-02
Value550
Percentage of BusinessCombinationConsiderationTransferred10.0

us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1

us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value2692-343.04700197809724381822300169-375.095485-148.079401618585104410.00.0
Percentage of BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual

abbv:Allerganplc


Business
Period End2020-12-31
Value400000000.0
Percentage of BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual100.0

us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual

abbv:Allerganplc


Business
Period End2020-12-31
Value4400
Percentage of BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual100.0

us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles

abbv:Allerganplc


Business
Period End2021-06-302021-03-31
Value0.0710
Percentage of BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles0.0100.0

us-gaap:CommonStockDividendsPerShareDeclared

us-gaap:CommonStockDividendsPerShareDeclared


Common
Period End2021-06-172021-02-182020-10-302020-12-312020-09-112020-06-172020-02-202019-11-012019-12-312019-09-062019-09-302019-06-202019-06-302019-02-212019-03-312018-11-022018-12-312018-09-072018-09-302018-06-142018-06-302018-02-152018-03-312017-10-272017-12-312017-09-082017-09-302017-06-222017-06-302017-02-162017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-01-042013-03-31
Value1.31.31.31.31.181.181.181.181.181.071.071.071.071.071.071.071.070.960.960.960.960.960.960.710.710.640.640.640.640.640.640.640.570.570.570.570.510.510.510.490.420.420.420.40.40.40.40.8
Percentage of CommonStockDividendsPerShareDeclared100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CommonStockDividendsPerShareDeclared us-gaap:SubsequentEventType

us-gaap:SubsequentEvent


Common
Period End2020-10-302019-11-012018-11-02
Value1.31.181.07
Percentage of CommonStockDividendsPerShareDeclared100.0100.0100.0

us-gaap:ConcentrationRiskPercentage1 us-gaap:ConcentrationRiskByBenchmark, us-gaap:ConcentrationRiskByType

us-gaap:ConcentrationRiskPercentage1

us-gaap:AccountsReceivable, us-gaap:GeographicConcentrationRisk


Concentration
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
Value72.00.70.630.520.490.410.480.340.41
Percentage of ConcentrationRiskPercentage1100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:SalesRevenueNet, us-gaap:ProductConcentrationRisk


Concentration
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
Value37.00.550.570.590.630.60.620.580.52
Percentage of ConcentrationRiskPercentage151.478.690.5113.5128.6146.3129.2170.6126.8

us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-06-302020-03-31
Value-9000000.0-10000000.0-1000000.0-1000000.0
Percentage of DefinedBenefitPlanAmortizationOfPriorServiceCostCredit100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-06-302020-03-31
Value01000000.001000000.0
Percentage of DefinedBenefitPlanAmortizationOfPriorServiceCostCredit-0.0-10.0-0.0-100.0

us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value1661661491481431351181181191191091091101119696
Percentage of DefinedBenefitPlanExpectedReturnOnPlanAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPlanInterestCost us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanInterestCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value4.05.09.08.08.09.08.06.09.06.07.06.04.08.06.06.0
Percentage of DefinedBenefitPlanInterestCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value60586868676165646664565757575152
Percentage of DefinedBenefitPlanInterestCost1500.01160.0755.6850.0837.5677.8812.51066.7733.31066.7800.0950.01425.0712.5850.0866.7

us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value1515252521271413171113136.0201213
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value78757070757341404438445658554242
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost520.0500.0280.0280.0357.1270.4292.9307.7258.8345.5338.5430.8966.7275.0350.0323.1

us-gaap:DefinedBenefitPlanServiceCost us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanServiceCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value12121110.09.0126.06.07.06.06.07.05.08.07.06.0
Percentage of DefinedBenefitPlanServiceCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value1091129393929267676867717072726059
Percentage of DefinedBenefitPlanServiceCost908.3933.3845.5930.01022.2766.71116.71116.7971.41116.71183.31000.01440.0900.0857.1983.3

us-gaap:Depreciation

us-gaap:Depreciation


Depreciation
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value201206227175149115118114114118122115119115101111110103118961081031211021049097941038999971009217393119140
Percentage of Depreciation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeGainLossOnDerivativeNet us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:DerivativeGainLossOnDerivativeNet

us-gaap:ForeignExchangeForward, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument, us-gaap:CostOfSales


Derivative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-09-30
Value-22.0-12.08.0150.00.048423740-17.0-54.0-46.0-44.017384617-3.04.0181.089
Percentage of DerivativeGainLossOnDerivativeNet100.0100.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ForeignExchangeForward, us-gaap:NetInvestmentHedging, us-gaap:DesignatedAsHedgingInstrument, us-gaap:InterestExpense


Derivative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value5.04.02.03.05.08.08.010.09.00.00.00.00.0
Percentage of DerivativeGainLossOnDerivativeNet-22.7-33.325.020.00.00.016.723.824.30.0-0.0-0.0-0.0

us-gaap:InterestRateSwap, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument, us-gaap:InterestExpense


Derivative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-06-302019-03-31
Value-7.0-7.0-7.0-8.0-3.01.00.00.0
Percentage of DerivativeGainLossOnDerivativeNet31.858.3-87.5-53.30.00.00.00.0

us-gaap:InterestRateSwap, us-gaap:FairValueHedging, us-gaap:DesignatedAsHedgingInstrument, us-gaap:InterestExpense


Derivative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-09-30
Value-11.0-57.0-33.01.037360-25.078253112235-63.0-59.0-184.0-106.01147-15.0-587.0-49.0116254235
Percentage of DerivativeGainLossOnDerivativeNet50.0475.0-412.56.70.00.0-52.1185.7683.8280.0-1382.4116.7128.3418.2-623.528.9102.2-88.219566.7-1225.0644.425400.0264.0

us-gaap:TreasuryLock, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument, us-gaap:InterestExpense


Derivative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-06-302019-03-31
Value6.06.06.06.06.06.00.00.0
Percentage of DerivativeGainLossOnDerivativeNet-27.3-50.075.040.00.00.00.00.0

us-gaap:DerivativeGainLossOnDerivativeNet us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:ForeignExchangeForward, us-gaap:Nondesignated, us-gaap:ForeignCurrencyGainLoss


Derivative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
Value-3.0-25.022313.02.025-55.0-25.015-8.022128-59.0-8.0-17.0-25.0-46.0128-15.0-42.0-65.015-5.04.0-169.0-290.0-215.0-18.0-1.0329.031-9.0-6.04.0
Percentage of DerivativeGainLossOnDerivativeNet13.6208.3275.0206.70.00.052.1-131.0-67.637.547.1-40.7-278.3134.1-47.1-44.7-54.3-270.6-4266.7-375.0-233.3-6500.00.0-5.60.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:DividendsCommonStockCash

us-gaap:DividendsCommonStockCash


Dividends
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-12-312013-09-302013-06-302013-03-31
Value23182316231621032105175417571595159115901595145314651532642641640638
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DividendsCommonStockCash us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings


Dividends
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-12-312013-09-302013-06-302013-03-31
Value23182316231621032105175417571595159115901595145314651532642641640638
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents

us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents


Effect
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value27-55.0276.08.0-46.014-16.08.01.0-10.0-9.0-35.0150.06.07.016-38.07.0-13.0-294.0
Percentage of EffectOfExchangeRateOnCashAndCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense


Employee
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value2648223238391615163312131929-12.020184721134248
Percentage of EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings


Fair
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value-2692.0343-4675.0-197.0-809.0-72.0-438.0-5126.02304169-383.095485-148.079
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings us-gaap:BusinessAcquisition

abbv:StemcentrxInc.


Fair
Period End2020-09-302019-12-312019-09-302018-12-31
Value91-428.091-428.0
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings-46.297.7-1.8111.7

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases


Fair
Period End2020-12-312020-09-302017-12-312017-09-302016-12-312016-09-302013-06-30
Value1040.00.00.00.0-145.028
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases100.00.00.00.00.0100.0100.0

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements


Fair
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value22513210983765355121670.00.0500.0240.03.01370.00.00.0131
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0100.00.0100.00.0100.0100.00.00.00.0100.0

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax


Foreign
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value-14.0-9.0-17.0-20.0-29.0-5.0-11.0-19.0-6.0-6.0-6.0-2.0-8.0-8.0-320.0-9.0-6.0-13.010.04.0-15.0-302.0-2.0-13.0-14.0-164.0-496.0-174.0-5.0-3.0-15.0-11.0-14.0-15.010.0-6.0-11.0-10.0
Percentage of ForeignCurrencyTransactionGainLossBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:GoodwillForeignCurrencyTranslationGainLoss

us-gaap:GoodwillForeignCurrencyTranslationGainLoss


Goodwill
Period End2021-03-31
Value-211.0
Percentage of GoodwillForeignCurrencyTranslationGainLoss100.0

us-gaap:GoodwillPurchaseAccountingAdjustments

us-gaap:GoodwillPurchaseAccountingAdjustments


Goodwill
Period End2021-06-302021-03-31
Value0.0-564.0
Percentage of GoodwillPurchaseAccountingAdjustments0.0100.0

us-gaap:GoodwillPurchaseAccountingAdjustments us-gaap:BusinessAcquisition

abbv:Allerganplc


Goodwill
Period End2021-06-302021-03-31
Value0.0-564.0
Percentage of GoodwillPurchaseAccountingAdjustments0.0100.0

us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill

us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill


Impairment
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value0.00.00.010000.00.00.00.00.00.00.0
Percentage of ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill0.00.00.0100.00.00.00.00.00.00.00.0

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value72236-389.01437-599.01065-539.0705-1381.094-691.0869-179.0191-19.0974-264.0-266.0-212.0-1064.04742175919221188-192.0216395-612.0-653.040924-206.0-497.0440-662.0-12.0
Percentage of IncreaseDecreaseInAccountsPayableAndAccruedLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1 us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:IncomeStatementLocation

us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1

us-gaap:FairValueHedging, us-gaap:InterestExpense


Increase
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value1157-1.0-37.0-360.0-78.0-253.0-112.06359184-11.0-47.015
Percentage of IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable

us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-753.0191-275.0-502.013191-291.093
Percentage of IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value-49.03305650-259.01986-280.0-15.011273-120.027926796-106.07553271-20.0-17.0159-59.0-151.040-341.0-40.01229219-422.099-107.0-29.0-96.0-37.0-20.063
Percentage of IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements


Incremental
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302013-06-30
Value7.06.02.05.00.03.00.02.04.03.00.04.04.05.01.06.05.06.00.08.08.09.00.0124.0
Percentage of IncrementalCommonSharesAttributableToShareBasedPaymentArrangements100.0100.0100.0100.00.0100.00.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0

us-gaap:InvestmentIncomeInterest

us-gaap:InvestmentIncomeInterest


Investment
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-31
Value9.010.010.01813560496237485841312621201510.08.06.0204.05.06.04.06.0112.01.0
Percentage of InvestmentIncomeInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:MinorityInterestPeriodIncreaseDecrease

us-gaap:MinorityInterestPeriodIncreaseDecrease


Minority
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value2.02.02.0-5.024
Percentage of MinorityInterestPeriodIncreaseDecrease100.0100.0100.0100.0100.0

us-gaap:MinorityInterestPeriodIncreaseDecrease us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest


Minority
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value2.02.02.0-5.024
Percentage of MinorityInterestPeriodIncreaseDecrease100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value244-677.0785512441-227.0190-256.071
Percentage of OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

abbv:AccumulatedNetGainLossFromNetInvestmentHedges


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-110.0377-342.0-312.0-209.078-104.0164
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-8.024-286.0-15.0-7.08.0-1342.010.0
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax7.36.483.64.83.310.31290.46.1

us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value244-677.0785512441-227.0190-256.0
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax-221.8-179.6-229.5-164.1-211.0-291.0-182.7-156.1

us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-8.035-59.0-47.0-6.04.022170
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax7.39.317.315.12.95.1-212.542.7

us-gaap:AccumulatedTranslationAdjustment


Other
Period End2020-09-302019-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value512320133-549.0-359.0-647.0-38.0-29.025
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax-164.1195.10.00.00.00.00.00.00.0

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value118-241.098138219-137.0-1035.0-10.0
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax-107.3-63.9-28.7-44.2-104.8-175.6995.2-6.1

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value0.03.0-10.0-9.0-2.0-2.06118-2.0
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax0.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax

us-gaap:ForeignExchangeForward, us-gaap:DesignatedAsHedgingInstrument


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value-11.035-66.0-52.0-2.049-13.03.02.03.0531.0169
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InterestRateSwap, us-gaap:DesignatedAsHedgingInstrument


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-06-302019-03-31
Value0.01.00.0-1.0-6.0-46.00.00.0
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax-0.02.9-0.01.9300.0-93.90.00.0

us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax

us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value1246-63.0-57.0-9.0-2.017331-33.0
Percentage of OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value1.0-25.017154.0-8.06.0-16.05.0
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax

us-gaap:ForeignExchangeForward, us-gaap:DesignatedAsHedgingInstrument


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value-14.099-63.0-56.0-16.040-36.05910.00.00.00.00.0
Percentage of OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax us-gaap:HedgingDesignation, us-gaap:LongtermDebtType

us-gaap:DesignatedAsHedgingInstrument, us-gaap:SeniorNotes


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-126.0382-375.0-340.0-252.060-97.0152498483-41.0-270.0-134.0-56.0-142.0
Percentage of OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax900.0385.9595.2607.11575.0150.0269.4257.6490.00.00.00.00.00.00.00.0

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-50.0-79.0236-35.0-43.0-56.01321-33.0-20.0
Percentage of OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-14.0-19.084-10.0-12.0-15.0342-7.0-6.0
Percentage of OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherNoncashIncomeExpense

us-gaap:OtherNoncashIncomeExpense


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value-87.020-341.0-57.0-433.0-1.049-102.0-23.033347-305.0-17.0-101.0-157.0207-89.0-45.0-103.0-252.0-12.0-62.0-120.026-146.0-249.0-110.0-384.01347-6.05.0-19.0-14.0-28.0-12.0-14.0-12.0
Percentage of OtherNoncashIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherOperatingIncomeExpenseNet

us-gaap:OtherOperatingIncomeExpenseNet


Other
Period End2021-06-30
Value68
Percentage of OtherOperatingIncomeExpenseNet100.0

us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic

us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic


Participating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-312014-09-30
Value1724161718141310.08.012-4.01210.0120.08.09.09.07.08.08.07.08.07.0-5.03.0
Percentage of ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted

us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted


Participating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
Value1724161718141310.08.012-4.01210.0120.08.09.09.07.08.08.07.08.07.07.05.0-5.03.07.04.09.06.0
Percentage of ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities

us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities


Payment
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302016-12-31
Value18113210983765343121080.00.0390.02680.0
Percentage of PaymentForContingentConsiderationLiabilityFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0100.00.0100.00.0

us-gaap:PaymentOfFinancingAndStockIssuanceCosts

us-gaap:PaymentOfFinancingAndStockIssuanceCosts


Payment
Period End2020-12-312020-09-302019-12-312019-09-302018-12-312018-09-302017-12-312017-09-302016-12-312016-09-302015-12-312015-09-302014-12-31
Value0.00.0176776.0340.00.0170.03.00.059
Percentage of PaymentOfFinancingAndStockIssuanceCosts0.00.0100.0100.0100.0100.00.00.0100.00.0100.00.0100.0

us-gaap:PaymentsForProceedsFromOtherInvestingActivities

us-gaap:PaymentsForProceedsFromOtherInvestingActivities


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-06-302019-03-31
Value-86.0-49.0-5.072-1459.05.00.00.0
Percentage of PaymentsForProceedsFromOtherInvestingActivities100.0100.0100.0100.0100.0100.00.00.0

us-gaap:PaymentsToAcquireBusinessesGross us-gaap:BusinessAcquisition

us-gaap:PaymentsToAcquireBusinessesGross

abbv:Luminera


Payments
Period End2020-10-31
Value122
Percentage of PaymentsToAcquireBusinessesGross100.0

us-gaap:PaymentsToAcquireBusinessesGross us-gaap:BusinessAcquisition, us-gaap:SubsequentEventType

abbv:Luminera, us-gaap:SubsequentEvent


Payments
Period End2020-10-31
Value121
Percentage of PaymentsToAcquireBusinessesGross99.2

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired


Payments
Period End2020-12-312020-09-302017-12-312017-09-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value1220.00.00.018222427280.00.01075273650555472241340.0-92.00.0109671
Percentage of PaymentsToAcquireBusinessesNetOfCashAcquired100.00.00.00.0100.0100.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.00.0100.00.0100.0100.0

us-gaap:PaymentsToAcquireMarketableSecurities

us-gaap:PaymentsToAcquireMarketableSecurities


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-312014-09-302013-12-312013-09-302012-12-31
Value4016141519134.021364194211944370267392447421970795500267813420.00.00.09.0299617725
Percentage of PaymentsToAcquireMarketableSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireOtherInvestments

us-gaap:PaymentsToAcquireOtherInvestments


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-312014-09-30
Value1471982788801801265936120320195140293721288037639040104281700.050555
Percentage of PaymentsToAcquireOtherInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities


Proceeds
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value5.0-4.0-20.08.0-5.025-1.0150.021-2.011-32.037-25.029-8.026-18.016-6.043-10.05.0-31.066-85.0-89.0-61.01810.025-4.0-97.0-139.0-4.01.0-9.0
Percentage of ProceedsFromPaymentsForOtherFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities us-gaap:DebtInstrument, us-gaap:LongtermDebtType

us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities

abbv:SeniorEuroNotesDue2021At0.500Percent, us-gaap:SeniorNotes


Proceeds
Period End2021-06-30
Value750
Percentage of ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities100.0

abbv:SeniorNotes2.30PercentDue2021, us-gaap:SeniorNotes


Proceeds
Period End2021-06-30
Value1800
Percentage of ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities240.0

abbv:SeniorNotesDueInMay2021AtFloatingRates, us-gaap:SeniorNotes


Proceeds
Period End2021-05-31
Value750
Percentage of ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities0.0

us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:SubsequentEventType

abbv:SeniorEuroNotesDue2021At0.500Percent, us-gaap:SeniorNotes, us-gaap:SubsequentEvent


Proceeds
Period End2021-06-30
Value750
Percentage of ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities100.0

abbv:SeniorNotes2.30PercentDue2021, us-gaap:SeniorNotes, us-gaap:SubsequentEvent


Proceeds
Period End2021-06-30
Value1800
Percentage of ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities240.0

us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments

us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments


Proceeds
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value541161351403264415894725942464031200311903544902444780476107033188531.08.017116062010.050015755230.01.0629
Percentage of ProceedsFromSaleMaturityAndCollectionsOfInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0

us-gaap:ProceedsFromStockOptionsExercised

us-gaap:ProceedsFromStockOptionsExercised


Proceeds
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value73711003265122.01.01.04.07.02.02.06240656485613892771922544761374285103549991
Percentage of ProceedsFromStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax us-gaap:StatementEquityComponents

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Reclassification
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-74.0-69.0-63.0-63.0-64.0-61.0-27.0-28.0-30.0
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax us-gaap:StatementEquityComponents

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

abbv:AccumulatedNetGainLossFromNetInvestmentHedges


Reclassification
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value4.03.02.02.04.06.06.08.0
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Reclassification
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-58.0-55.0-50.0-50.0-50.0-48.0-21.0-23.0-23.0
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax-1450.0-1833.3-2500.0-2500.0-1250.0-800.0-350.0-287.50.0

us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterest


Reclassification
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-20.0-11.04.010.03.06.04839
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax-500.0-366.7200.0500.075.0100.0800.0487.5

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest


Reclassification
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-74.0-63.0-44.0-38.0-43.0-36.03327
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax-1850.0-2100.0-2200.0-1900.0-1075.0-600.0550.0337.5

us-gaap:ReclassificationFromAociCurrentPeriodTax us-gaap:StatementEquityComponents

us-gaap:ReclassificationFromAociCurrentPeriodTax

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest


Reclassification
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-16.0-14.0-13.0-13.0-14.0-13.0-6.0-5.0-7.0
Percentage of ReclassificationFromAociCurrentPeriodTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities

us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities


Repayments
Period End2020-12-312020-09-302019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value126965115311.04.00.01014200830067.07.05.07.06.040041.020050.040034.0
Percentage of RepaymentsOfLongTermDebtAndCapitalSecurities100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0

us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities us-gaap:DebtInstrument, us-gaap:LongtermDebtType

abbv:SeniorEuroNotesDue2020AtFloatingRates, us-gaap:SeniorNotes


Repayments
Period End2020-11-30
Value700
Percentage of RepaymentsOfLongTermDebtAndCapitalSecurities0.0

abbv:SeniorNotesDue2020At3.375Percent, us-gaap:SeniorNotes


Repayments
Period End2020-09-30
Value650
Percentage of RepaymentsOfLongTermDebtAndCapitalSecurities99.8

abbv:SeniorNotesDueIn2021At4.875Percent, us-gaap:SeniorNotes


Repayments
Period End2020-11-30
Value450
Percentage of RepaymentsOfLongTermDebtAndCapitalSecurities0.0

us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff

us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff


Research
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value9770300458530.01390.091155300550.0693120.0150.040807010.00.00.023127283081648220700.0280.0110150
Percentage of ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff100.0100.0100.0100.0100.00.0100.00.0100.0100.0100.0100.00.0100.0100.00.0100.00.0100.0100.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.00.0100.0100.0

us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement

abbv:GenmabAS, us-gaap:InProcessResearchAndDevelopment, us-gaap:CollaborativeArrangement


Research
Period End2020-12-312020-06-30
Value0.0750
Percentage of ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff0.087.9

us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement

abbv:IMabBiopharma, srt:ScenarioForecast, us-gaap:InProcessResearchAndDevelopment, us-gaap:CollaborativeArrangement


Research
Period End2020-12-31
Value200
Percentage of ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff66.7

abbv:TeneoOneAndTNB383B, srt:ScenarioForecast, us-gaap:InProcessResearchAndDevelopment, us-gaap:CollaborativeArrangement


Research
Period End2021-09-30
Value400
Percentage of ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff0.0

us-gaap:RestructuringAndRelatedCostIncurredCost us-gaap:IncomeStatementLocation, us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan

us-gaap:RestructuringAndRelatedCostIncurredCost

us-gaap:CostOfSales, us-gaap:EmployeeSeverance, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value0.06.06610.033
Percentage of RestructuringAndRelatedCostIncurredCost0.0100.0100.0100.0100.0

us-gaap:CostOfSales, us-gaap:OtherRestructuring, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value25158.0121.0
Percentage of RestructuringAndRelatedCostIncurredCost0.0250.012.1120.03.0

us-gaap:ResearchAndDevelopmentExpense, us-gaap:EmployeeSeverance, abbv:AllerganIntegrationPlan


Restructuring
Period End2020-12-312020-09-302020-06-30
Value2740132
Percentage of RestructuringAndRelatedCostIncurredCost40.9400.0400.0

us-gaap:ResearchAndDevelopmentExpense, us-gaap:OtherRestructuring, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value1851429144
Percentage of RestructuringAndRelatedCostIncurredCost0.0850.063.6910.0133.3

us-gaap:SellingGeneralAndAdministrativeExpenses, us-gaap:EmployeeSeverance, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value12174129318
Percentage of RestructuringAndRelatedCostIncurredCost0.0283.362.1290.0963.6

us-gaap:SellingGeneralAndAdministrativeExpenses, us-gaap:OtherRestructuring, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value755082576038
Percentage of RestructuringAndRelatedCostIncurredCost0.0833.3124.2570.0181.80.0

us-gaap:RestructuringAndRelatedCostIncurredCost us-gaap:RestructuringCostAndReserve, us-gaap:RestructuringPlan

us-gaap:EmployeeSeverance, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value122313479483
Percentage of RestructuringAndRelatedCostIncurredCost0.0383.3203.0790.01463.6

us-gaap:OtherRestructuring, abbv:AllerganIntegrationPlan


Restructuring
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value11811613216010538
Percentage of RestructuringAndRelatedCostIncurredCost0.01933.3200.01600.0318.20.0

us-gaap:RestructuringAndRelatedCostIncurredCost us-gaap:RestructuringPlan

abbv:OtherRestructuringPlans


Restructuring
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-30
Value5.0381114172219
Percentage of RestructuringAndRelatedCostIncurredCost0.0633.3110.042.40.00.00.0

us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer abbv:KeyProductPortfolio, us-gaap:ProductOrService, us-gaap:StatementGeographical

us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer

abbv:HematologicOncology, abbv:Imbruvica, us-gaap:NonUs


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value282269259251233266223215213193167160
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:CounterpartyName, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

abbv:JanssenBiotechInc, us-gaap:NonUs, us-gaap:CollaborativeArrangement


Revenue
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-30
Value282269251233266215213
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-31
Value01100000.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross0.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-12-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value016.28000.010.039.250009.960009.830006.87
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue0.0100.00.00.0100.0100.0100.00.00.00.0100.00.00.00.0100.00.00.00.0100.0

us-gaap:StockIssuedDuringPeriodSharesAcquisitions us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodSharesAcquisitions

us-gaap:CommonStock


Stock
Period End2020-12-312020-09-302020-06-30
Value0.00.0286
Percentage of StockIssuedDuringPeriodSharesAcquisitions0.00.0100.0

us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation

us-gaap:CommonStock


Stock
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1.08.03.01.01.05.00.01.00.04.01.00.00.07.0
Percentage of StockIssuedDuringPeriodSharesShareBasedCompensation100.0100.0100.0100.0100.0100.00.0100.00.0100.0100.00.00.0100.0

us-gaap:StockIssuedDuringPeriodValueAcquisitions

us-gaap:StockIssuedDuringPeriodValueAcquisitions


Stock
Period End2020-12-312020-09-302020-06-30
Value0.00.024409
Percentage of StockIssuedDuringPeriodValueAcquisitions0.00.0100.0

us-gaap:StockIssuedDuringPeriodValueAcquisitions us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Stock
Period End2020-12-312020-09-302020-06-30
Value0.00.01243
Percentage of StockIssuedDuringPeriodValueAcquisitions0.00.05.1

us-gaap:TreasuryStock


Stock
Period End2020-12-312020-09-302020-06-30
Value0.00.023166
Percentage of StockIssuedDuringPeriodValueAcquisitions0.00.094.9

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation


Stock
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-12-312013-09-302013-06-302013-03-31
Value229362240201314245819188209768979272171124198-7.0
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Stock
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-12-312013-09-302013-06-302013-03-31
Value22432823619530920881848818476847724914912222290
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation97.890.698.397.098.484.9100.092.3100.088.0100.094.497.591.587.198.4112.1-1285.7

us-gaap:TreasuryStock


Stock
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-12-312013-09-302013-06-302013-03-31
Value5.0344.06.05.0370.07.00.0250.05.02.023222.0-24.0-97.0
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation2.29.41.73.01.615.10.07.70.012.00.05.62.58.512.91.6-12.11385.7

us-gaap:TreasuryStockSharesAcquired us-gaap:ShareRepurchaseProgram

us-gaap:TreasuryStockSharesAcquired

abbv:December2018StockRepurchaseAuthorization


Treasury
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value0.05.02.00.00.06.00.00.00.04.0
Percentage of TreasuryStockSharesAcquired0.0100.0100.00.00.0100.00.00.00.0100.0

us-gaap:TreasuryStockSharesAcquired us-gaap:StatementEquityComponents

us-gaap:CommonStock


Treasury
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0.07.03.00.00.07.00.00.00.05.02610.07312
Percentage of TreasuryStockSharesAcquired0.0140.0150.00.00.0116.70.00.00.0125.00.00.00.00.0

us-gaap:TreasuryStockValueAcquiredCostMethod

us-gaap:TreasuryStockValueAcquiredCostMethod


Treasury
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value10.078729620196433.03.03.04192259100975161431
Percentage of TreasuryStockValueAcquiredCostMethod100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStockValueAcquiredCostMethod us-gaap:ShareRepurchaseProgram

abbv:December2018StockRepurchaseAuthorization


Treasury
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value0.05502570.00.05000.00.00.0300
Percentage of TreasuryStockValueAcquiredCostMethod0.069.986.80.00.077.80.00.00.071.6

us-gaap:TreasuryStockValueAcquiredCostMethod us-gaap:StatementEquityComponents

us-gaap:TreasuryStock


Treasury
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value10.078729620196433.03.03.04192259100975161431
Percentage of TreasuryStockValueAcquiredCostMethod100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:AccruedSalesRebates

abbv:AccruedSalesRebates


Accrued
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value718844843939306928872355138414011616
Percentage of AccruedSalesRebates100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:AdditionalContributionToAcquireInProcessResearchAndDevelopmentCollaborations us-gaap:BusinessAcquisition

abbv:AdditionalContributionToAcquireInProcessResearchAndDevelopmentCollaborations

abbv:Luminera


Additional
Period End2020-10-31
Value90
Percentage of AdditionalContributionToAcquireInProcessResearchAndDevelopmentCollaborations100.0

abbv:ConsiderationReceivableFromCounterpartyForReacquiredRights us-gaap:CounterpartyName

abbv:ConsiderationReceivableFromCounterpartyForReacquiredRights

abbv:ReataPharmaceuticalsInc


Consideration
Period End2020-12-31
Value80
Percentage of ConsiderationReceivableFromCounterpartyForReacquiredRights100.0

abbv:DeferredTaxAssetsChargebacksAndRebates

abbv:DeferredTaxAssetsChargebacksAndRebates


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value555477417305473472297333403
Percentage of DeferredTaxAssetsChargebacksAndRebates100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:DeferredTaxAssetsOperatingLossAndOtherTaxCreditCarryforwards

abbv:DeferredTaxAssetsOperatingLossAndOtherTaxCreditCarryforwards


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value276583822820815128212511592
Percentage of DeferredTaxAssetsOperatingLossAndOtherTaxCreditCarryforwards100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:LeaseLiability

abbv:LeaseLiability


Lease
Period End2020-12-312019-12-312019-09-302019-06-30
Value1036387403432
Percentage of LeaseLiability100.0100.0100.0100.0

abbv:LeaseLiabilityPaymentsDue

abbv:LeaseLiabilityPaymentsDue


Lease
Period End2020-12-31
Value1154
Percentage of LeaseLiabilityPaymentsDue100.0

abbv:LeaseLiabilityPaymentsDueNextRollingTwelveMonths

abbv:LeaseLiabilityPaymentsDueNextRollingTwelveMonths


Lease
Period End2020-12-31
Value229
Percentage of LeaseLiabilityPaymentsDueNextRollingTwelveMonths100.0

abbv:LeaseLiabilityPaymentsDueYearFive

abbv:LeaseLiabilityPaymentsDueYearFive


Lease
Period End2020-12-31
Value96
Percentage of LeaseLiabilityPaymentsDueYearFive100.0

abbv:LeaseLiabilityPaymentsDueYearFour

abbv:LeaseLiabilityPaymentsDueYearFour


Lease
Period End2020-12-31
Value112
Percentage of LeaseLiabilityPaymentsDueYearFour100.0

abbv:LeaseLiabilityPaymentsDueYearThree

abbv:LeaseLiabilityPaymentsDueYearThree


Lease
Period End2020-12-31
Value142
Percentage of LeaseLiabilityPaymentsDueYearThree100.0

abbv:LeaseLiabilityPaymentsDueYearTwo

abbv:LeaseLiabilityPaymentsDueYearTwo


Lease
Period End2020-12-31
Value181
Percentage of LeaseLiabilityPaymentsDueYearTwo100.0

abbv:LeaseLiabilityPaymentsDueafterYearFive

abbv:LeaseLiabilityPaymentsDueafterYearFive


Lease
Period End2020-12-31
Value394
Percentage of LeaseLiabilityPaymentsDueafterYearFive100.0

abbv:LeaseLiabilityUndiscountedExcessAmount

abbv:LeaseLiabilityUndiscountedExcessAmount


Lease
Period End2020-12-31
Value118
Percentage of LeaseLiabilityUndiscountedExcessAmount100.0

abbv:LeaseRightofUseAsset

abbv:LeaseRightofUseAsset


Lease
Period End2020-12-312019-12-31
Value922367
Percentage of LeaseRightofUseAsset100.0100.0

abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel

abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure

us-gaap:FairValueInputsLevel1


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302015-12-312015-06-302015-03-312014-12-31
Value76361086282494279455037503753528653481576160999999839974004300429990.00.00.00.0398740074012
Percentage of LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0100.0100.0100.0

abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

us-gaap:FairValueInputsLevel1, us-gaap:EstimateOfFairValueFairValueDisclosure


Long
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value82493753160940040.00.0
Percentage of LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure100.0100.0100.0100.00.00.0

us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value2895382934537757.07.08.02030252016
Percentage of LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure3.85.03.610.617.00.20.20.550.70.00.0

abbv:LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure us-gaap:FairValueByMeasurementBasis

us-gaap:CarryingReportedAmountFairValueDisclosure


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value78841133184614709529337563755528453431579160910263026602460233021302025252623202320258.0400740214021222018182322
Percentage of LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure103.2104.3102.6110.0116.3100.2100.1100.099.9100.2100.0102.7303.2150.7150.4100.6100.70.00.00.00.00.00.00.0100.5100.3100.20.00.00.00.00.00.0

us-gaap:EstimateOfFairValueFairValueDisclosure


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value792511400854247325325375737605293535715861617102530266026603430273022252526232018201624401040294033222018182322
Percentage of LongTermDebtAndCapitalLeaseObligationsCurrentFairValueDisclosure103.8105.0103.6110.6117.0100.2100.2100.1100.2100.6100.5102.6303.2150.8150.7100.8100.80.00.00.00.00.00.00.0100.6100.5100.50.00.00.00.00.00.0

abbv:LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedDiscounts

abbv:LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedDiscounts


Long
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value1461611209711085495671
Percentage of LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedDiscounts100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedFinancingCosts

abbv:LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedFinancingCosts


Long
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value28732316314616411734
Percentage of LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedFinancingCosts100.0100.0100.0100.0100.0100.0100.0

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure

us-gaap:FairValueInputsLevel1


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value80747789758613788589886966615766631349433273135339340243632030675314943276333575331153489634589363583612528155270613092926924108031073714440145811460914413
Percentage of LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

us-gaap:FairValueInputsLevel1, us-gaap:EstimateOfFairValueFairValueDisclosure


Long
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value861376663134024327633458927061
Percentage of LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value132313051624161215921920288320752082
Percentage of LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure1.61.71.91.81.80.00.00.10.36.07.7

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure us-gaap:FairValueByMeasurementBasis

us-gaap:CarryingReportedAmountFairValueDisclosure


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value740517398177283819728174062974630213314131712354203546837187312163148131346342693412336879367783703537030293082931231303272951074210745147381473014732147241437514630
Percentage of LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure91.793.789.792.592.295.294.694.896.9100.2104.2102.4101.8100.095.7102.1103.0105.7106.3101.9102.5104.1108.3101.2101.499.4100.1102.1101.0100.8102.20.00.0

us-gaap:EstimateOfFairValueFairValueDisclosure


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value820708028087761902019028866176666513496432753353623405236392307503157232846356473518736976366643842638190302062914331023270171089310830145221466614696144931422415066
Percentage of LongTermDebtAndCapitalLeaseObligationsFairValueDisclosure101.6101.7101.9101.8101.8100.0100.0100.1100.1100.1100.1100.2100.2100.2100.3106.2106.3106.0106.0105.7105.7107.3107.7100.3100.3100.8100.9100.6100.6100.6100.60.00.0

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueHedgesNet

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueHedgesNet


Long
Period End2020-12-312019-12-31
Value-278.048
Percentage of LongTermDebtAndCapitalLeaseObligationsFairValueHedgesNet100.0100.0

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueHedgesUnamortizedBondPremiumsAndDiscountsDeferredFinancingCostsAndFinanceLeaseObligations

abbv:LongTermDebtAndCapitalLeaseObligationsFairValueHedgesUnamortizedBondPremiumsAndDiscountsDeferredFinancingCostsAndFinanceLeaseObligations


Long
Period End2020-12-31
Value-1074000000.0
Percentage of LongTermDebtAndCapitalLeaseObligationsFairValueHedgesUnamortizedBondPremiumsAndDiscountsDeferredFinancingCostsAndFinanceLeaseObligations100.0

abbv:LongTermDebtAndCapitalLeaseObligationsGross us-gaap:DebtInstrument

abbv:LongTermDebtAndCapitalLeaseObligationsGross

abbv:OtherLongTermDebt


Long
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value292736110113139
Percentage of LongTermDebtAndCapitalLeaseObligationsGross100.0100.0100.0100.0100.0100.0

abbv:LongTermDebtAndCapitalLeaseObligationsGross us-gaap:DebtInstrument, us-gaap:LongtermDebtType

abbv:FloatingRateTermLoanTrancheDueMay2023, us-gaap:LoansPayable


Long
Period End2020-12-31
Value1000
Percentage of LongTermDebtAndCapitalLeaseObligationsGross3448.3

abbv:FloatingRateTermLoanTrancheDueMay2025, us-gaap:LoansPayable


Long
Period End2020-12-31
Value2000
Percentage of LongTermDebtAndCapitalLeaseObligationsGross6896.6

abbv:SeniorEuroNotes1375PercentDue2024, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value17831625
Percentage of LongTermDebtAndCapitalLeaseObligationsGross6148.36018.5

abbv:SeniorEuroNotes2125PercentDue2028, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value922840
Percentage of LongTermDebtAndCapitalLeaseObligationsGross3179.33111.1

abbv:SeniorEuroNotesDue2021At0.500Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value922
Percentage of LongTermDebtAndCapitalLeaseObligationsGross3179.3

abbv:SeniorEuroNotesDue2023At1.500Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value615
Percentage of LongTermDebtAndCapitalLeaseObligationsGross2120.7

abbv:SeniorEuroNotesDue2024At1.250Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value861
Percentage of LongTermDebtAndCapitalLeaseObligationsGross2969.0

abbv:SeniorEuroNotesDue2028At2.625Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value615
Percentage of LongTermDebtAndCapitalLeaseObligationsGross2120.7

abbv:SeniorEuroNotesDue2029At2.125Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value677
Percentage of LongTermDebtAndCapitalLeaseObligationsGross2334.5

abbv:SeniorEuroNotesDuein2027at0.750Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value9228400.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross3179.33111.10.0

abbv:SeniorEuroNotesDuein2031at1.250Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value7997280.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross2755.22696.30.0

abbv:SeniorNotesDue2021At5.000Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value1200
Percentage of LongTermDebtAndCapitalLeaseObligationsGross4137.9

abbv:SeniorNotesDue2022At3.250Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value1700
Percentage of LongTermDebtAndCapitalLeaseObligationsGross5862.1

abbv:SeniorNotesDue2022At3.450Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value2878
Percentage of LongTermDebtAndCapitalLeaseObligationsGross9924.1

abbv:SeniorNotesDue2023At2.800Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value350
Percentage of LongTermDebtAndCapitalLeaseObligationsGross1206.9

abbv:SeniorNotesDue2024at3.850Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value1032
Percentage of LongTermDebtAndCapitalLeaseObligationsGross3558.6

abbv:SeniorNotesDue2025at3.800Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value3021
Percentage of LongTermDebtAndCapitalLeaseObligationsGross10417.2

abbv:SeniorNotesDue2035at4.550Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value1789
Percentage of LongTermDebtAndCapitalLeaseObligationsGross6169.0

abbv:SeniorNotesDue2042at4.625Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value457
Percentage of LongTermDebtAndCapitalLeaseObligationsGross1575.9

abbv:SeniorNotesDue2044at4.850, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value1074
Percentage of LongTermDebtAndCapitalLeaseObligationsGross3703.4

abbv:SeniorNotesDue2045at4.750Percent, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value881
Percentage of LongTermDebtAndCapitalLeaseObligationsGross3037.9

abbv:SeniorNotesDuein2021At2.15Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value175017500.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross6034.56481.50.0

abbv:SeniorNotesDuein2022At2.30Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value300030000.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross10344.811111.10.0

abbv:SeniorNotesDuein2022AtFloatingRates, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value7507500.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross2586.22777.80.0

abbv:SeniorNotesDuein2024At2.60Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value375037500.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross12931.013888.90.0

abbv:SeniorNotesDuein2026At2.95Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value400040000.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross13793.114814.80.0

abbv:SeniorNotesDuein2029At3.20Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value550055000.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross18965.520370.40.0

abbv:SeniorNotesDuein2039At4.05Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value400040000.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross13793.114814.80.0

abbv:SeniorNotesDuein2049At4.25Percent, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value575057500.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross19827.621296.30.0

abbv:SeniorNotesDueinMay2021AtFloatingRates, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value7507500.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross2586.22777.80.0

abbv:SeniorNotesDueinNovember2021AtFloatingRates, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-312018-12-31
Value7507500.0
Percentage of LongTermDebtAndCapitalLeaseObligationsGross2586.22777.80.0

abbv:LongTermDebtAndFinanceLeaseObligationsDebtInstrumentUnamortizedPremiums

abbv:LongTermDebtAndFinanceLeaseObligationsDebtInstrumentUnamortizedPremiums


Long
Period End2020-12-31
Value1200
Percentage of LongTermDebtAndFinanceLeaseObligationsDebtInstrumentUnamortizedPremiums100.0

abbv:NumberOfCasesConsolidatedForPreTrialPurposes us-gaap:LitigationCase

abbv:NumberOfCasesConsolidatedForPreTrialPurposes

abbv:TestosteroneReplacementTherapyProductsLiabilityLitigation


Number
Period End2020-09-30
Value3500.0
Percentage of NumberOfCasesConsolidatedForPreTrialPurposes100.0

abbv:PotentialPaymentsUnderAgreementCertainMilestones us-gaap:CounterpartyName, us-gaap:Range, us-gaap:StatementScenario, us-gaap:TypeOfArrangement

abbv:PotentialPaymentsUnderAgreementCertainMilestones

abbv:TeneoOneAndTNB383B, srt:Maximum, srt:ScenarioForecast, us-gaap:CollaborativeArrangement


Potential
Period End2021-09-30
Value250
Percentage of PotentialPaymentsUnderAgreementCertainMilestones100.0

abbv:PotentialPaymentsUnderAgreementCertainMilestones us-gaap:CounterpartyName, us-gaap:Range, us-gaap:TypeOfArrangement

abbv:OtherCollaborationArrangements, srt:Maximum, us-gaap:CollaborativeArrangement


Potential
Period End2020-12-31
Value5100
Percentage of PotentialPaymentsUnderAgreementCertainMilestones0.0

abbv:PotentialPaymentsUnderAgreementCertainMilestones us-gaap:CounterpartyName, us-gaap:StatementScenario, us-gaap:TypeOfArrangement

abbv:IMabBiopharma, srt:ScenarioForecast, us-gaap:CollaborativeArrangement


Potential
Period End2020-12-31
Value1700
Percentage of PotentialPaymentsUnderAgreementCertainMilestones0.0

abbv:PotentialPaymentsUnderAgreementCertainMilestones us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

abbv:GenmabAS, us-gaap:CollaborativeArrangement


Potential
Period End2020-09-30
Value3200
Percentage of PotentialPaymentsUnderAgreementCertainMilestones0.0

abbv:IMabBiopharma, us-gaap:CollaborativeArrangement


Potential
Period End2020-12-31
Value1700
Percentage of PotentialPaymentsUnderAgreementCertainMilestones0.0

abbv:ReimbursementReceivableForUnrecognizedTaxBenefitAndRelatedInterestAndPenalties

abbv:ReimbursementReceivableForUnrecognizedTaxBenefitAndRelatedInterestAndPenalties


Reimbursement
Period End2020-12-31
Value81
Percentage of ReimbursementReceivableForUnrecognizedTaxBenefitAndRelatedInterestAndPenalties100.0

abbv:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageGrantDateFairValue us-gaap:AwardType

abbv:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageGrantDateFairValue

abbv:RestrictedStockUnitsAndPerformanceShares


Share
Period End2020-12-312019-12-312018-12-31
Value87.0381.7279.9
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageGrantDateFairValue100.0100.0100.0

abbv:UnrecognizedTaxBenefitsLiabilities

abbv:UnrecognizedTaxBenefitsLiabilities


Unrecognized
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value56802772272626831166902471
Percentage of UnrecognizedTaxBenefitsLiabilities100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccruedIncomeTaxesNoncurrent

us-gaap:AccruedIncomeTaxesNoncurrent


Accrued
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value38473453431146750.0
Percentage of AccruedIncomeTaxesNoncurrent100.0100.0100.0100.00.0

us-gaap:AccruedRoyaltiesCurrent

us-gaap:AccruedRoyaltiesCurrent


Accrued
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value483324304514434411821443398
Percentage of AccruedRoyaltiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax us-gaap:RetirementPlanType

us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Accumulated
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value744533.0291142
Percentage of AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Accumulated
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value41713643252724832132
Percentage of AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax5636.5804.284233.3853.31501.4

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent


Allowance
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value2624651587278748883
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:AssetsFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value29963128290729741527127215661350146713161213658876102285372693379212671084102614099099431188100712273502602630694542473821987
Percentage of AssetsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value5940702359525346487040108384389615545454238316962744391048311001108058350762771228508872677807679841371867113735470459703852492289088833866907016
Percentage of AssetsFairValueDisclosure198.3224.5204.7179.8318.93153.12454.5712.2371.8412.1685.61463.1506.71025.71289.71488.3895.0963.0562.1784.9850.5552.2844.8892.2604.9706.4599.3201.21611.81353.01329.71676.81762.8814.9710.8

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value893610151885983206397413804000410965692167399529102855315115051185411531928384198389959297529189858893568581
Percentage of AssetsFairValueDisclosure298.3324.5304.7279.8418.93253.12554.5812.2471.8512.1785.61563.1606.71125.71389.71588.3995.01063.0662.1884.9950.5652.2944.8992.2699.3

us-gaap:AvailableForSaleSecuritiesDebtSecurities us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:AvailableForSaleSecuritiesDebtSecurities

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value71495053503.03.02.0157316111536159115492471252424752527249019741476
Percentage of AvailableForSaleSecuritiesDebtSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesDebtSecurities us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value71495053503.03.02.0157316111536159115492471252424752527249019741476
Percentage of AvailableForSaleSecuritiesDebtSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessCombinationContingentConsiderationLiability us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationContingentConsiderationLiability

abbv:Luminera


Business
Period End2020-10-31
Value64
Percentage of BusinessCombinationContingentConsiderationLiability100.0

us-gaap:BusinessCombinationContingentConsiderationLiability us-gaap:BusinessAcquisition, us-gaap:SubsequentEventType

abbv:Luminera, us-gaap:SubsequentEvent


Business
Period End2020-10-31
Value90
Percentage of BusinessCombinationContingentConsiderationLiability140.6

us-gaap:BusinessCombinationContingentConsiderationLiability us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value149891252212997832782137359734069576789465244834866482143864534445543594298421341284171242427165160251
Percentage of BusinessCombinationContingentConsiderationLiability0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:BusinessCombinationContingentConsiderationLiability us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value149891252212997832782137359734069576789465244834866482143864534445543594298421341284171
Percentage of BusinessCombinationContingentConsiderationLiability0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput us-gaap:MeasurementInputType

us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput

abbv:ProbabilityofPaymentforApprovedIndications


Business
Period End2021-03-312020-12-312020-09-302020-06-302020-03-31
Value100.0100.0100.01.01.0
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput100.0100.0100.0100.0100.0

us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput us-gaap:Range, us-gaap:MeasurementInputType

srt:Maximum, abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndications


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value89.089.089.056.00.560.56
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.089.089.056.056.056.0

srt:Maximum, abbv:ProbabilityofPaymentforRoyaltiesbyIndication


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value100.0100.0100.01.01.01.0
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.0100.0100.01.0100.0100.0

srt:Maximum, abbv:ProbabilityofPaymentforUnachievedMilestones


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value92.092.092.00.570.570.57
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.092.092.00.657.057.0

srt:Maximum, us-gaap:MeasurementInputDiscountRate


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value2.52.92.20.0260.0260.035
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.02.92.20.02.63.5

srt:Minimum, abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndications


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value56.056.056.016.00.160.16
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.056.056.016.016.016.0

srt:Minimum, abbv:ProbabilityofPaymentforRoyaltiesbyIndication


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value56.056.056.00.160.160.16
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.056.056.00.216.016.0

srt:Minimum, abbv:ProbabilityofPaymentforUnachievedMilestones


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value56.056.056.00.160.160.16
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.056.056.00.216.016.0

srt:Minimum, us-gaap:MeasurementInputDiscountRate


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value0.10.20.10.0020.0050.022
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.00.20.10.00.52.2

srt:WeightedAverage, abbv:ProbabilityofPaymentforRoyaltiesbyIndication


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value95.090.091.089.00.890.89
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.090.091.089.089.089.0

srt:WeightedAverage, abbv:ProbabilityofPaymentforUnachievedMilestones


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value87.064.064.054.00.540.54
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.064.064.054.054.054.0

srt:WeightedAverage, us-gaap:MeasurementInputDiscountRate


Business
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value1.41.71.11.50.0160.028
Percentage of BusinessCombinationContingentConsiderationLiabilityMeasurementInput0.01.71.11.51.62.8

us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent

us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent


Business
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value1228972014306426639410.0
Percentage of BusinessCombinationContingentConsiderationLiabilityNoncurrent100.0100.0100.0100.0100.00.0

us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets

abbv:Luminera


Business
Period End2020-10-31
Value33
Percentage of BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets100.0

us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles

abbv:Luminera


Business
Period End2020-10-31
Value127
Percentage of BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles100.0

us-gaap:CashAndCashEquivalentsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:CashAndCashEquivalentsFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value2886298127582836143212721542128813881264120965386710218496698527271191991949134979891011369921214896590618684533462510675
Percentage of CashAndCashEquivalentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value5660677456915054458539870383829360378436336080736226807986845477775236401339095227537862077601831362646914713468238496752289118442472122985226
Percentage of CashAndCashEquivalentsFairValueDisclosure196.1227.2206.3178.2320.23134.42489.1726.7272.6287.4502.91127.4309.1782.2995.81162.5614.6552.0328.2527.4566.7460.1952.5913.5551.4697.0587.6761.51440.01217.21302.81583.91021.9450.6774.2

us-gaap:CashAndCashEquivalentsFairValueDisclosure us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value8546975584497890601741142399241064851724897728980153547900793038446608847405100621863277556839992238348
Percentage of CashAndCashEquivalentsFairValueDisclosure296.1327.2306.3278.2420.23234.42589.1826.7372.6387.4602.91227.4409.1882.21095.81262.5714.6652.0428.2627.4666.7560.11052.51013.5687.6

us-gaap:CommonStockValueOutstanding

us-gaap:CommonStockValueOutstanding


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value18181818181818181818181818181818181818181818171717161616161616
Percentage of CommonStockValueOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtInstrumentUnamortizedPremium us-gaap:DebtInstrument

us-gaap:DebtInstrumentUnamortizedPremium

abbv:AllerganSeniorNotesAcquired


Debt
Period End2020-09-30
Value1256
Percentage of DebtInstrumentUnamortizedPremium100.0

us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible

us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible


Decrease
Period End2021-06-302021-03-312020-12-312020-09-30
Value11611668138
Percentage of DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible100.0100.0100.0100.0

us-gaap:DeferredIncomeTaxLiabilities

us-gaap:DeferredIncomeTaxLiabilities


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value6591340134014146874274176571114500
Percentage of DeferredIncomeTaxLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsDeferredIncome

us-gaap:DeferredTaxAssetsDeferredIncome


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value324615867219391372382348283
Percentage of DeferredTaxAssetsDeferredIncome100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsGross


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value656235172765203221532439215215801544
Percentage of DeferredTaxAssetsGross100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsOther

us-gaap:DeferredTaxAssetsOther


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value137140635342971316230122274
Percentage of DeferredTaxAssetsOther100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value1109810529556665584627279190
Percentage of DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value438371371315378368376252173
Percentage of DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value527427122940376253754459331508500
Percentage of DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxLiabilitiesInvestments

us-gaap:DeferredTaxLiabilitiesInvestments


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value33524921118133672958326
Percentage of DeferredTaxLiabilitiesInvestments100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxLiabilitiesOther

us-gaap:DeferredTaxLiabilitiesOther


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value982440250203182
Percentage of DeferredTaxLiabilitiesOther100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation

us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value1050076006000630053004800
Percentage of DefinedBenefitPlanAccumulatedBenefitObligation100.0100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value-482000000.0-469000000.0-25000000.0-320000000.0-179000000.0
Percentage of DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value-4163000000.0-3633000000.0-2516000000.0-2471000000.0-2118000000.0
Percentage of DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax863.7774.610064.0772.21183.2

us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value-408.0-16.0-22.0-29.0-37.0
Percentage of DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value8.010.0111214
Percentage of DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax-2.0-62.5-50.0-41.4-37.8

us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value-795.0-1050.0-561.0-813.0-627.0
Percentage of DefinedBenefitPlanAmountsRecognizedInBalanceSheet100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value-2090.0-1530.0-981.0-1586.0-1257.0
Percentage of DefinedBenefitPlanAmountsRecognizedInBalanceSheet262.9145.7174.9195.1200.5

us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value563395321388240
Percentage of DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value2.80.0360.0460.0390.047
Percentage of DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value2.40.030.040.0340.039
Percentage of DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate85.783.387.087.283.0

us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value4.60.0460.0460.0450.044
Percentage of DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPlanBenefitObligation us-gaap:RetirementPlanSponsorLocation

us-gaap:DefinedBenefitPlanBenefitObligation

us-gaap:ForeignPlan


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-31
Value35002300190020001700
Percentage of DefinedBenefitPlanBenefitObligation100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPlanBenefitObligation us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value7951050561813627557
Percentage of DefinedBenefitPlanBenefitObligation22.745.729.540.636.90.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value1179286466618698558295387
Percentage of DefinedBenefitPlanBenefitObligation336.9375.9348.3349.2342.90.0

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value217186135153
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value2169173715891474
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter999.5933.91177.0963.4

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value23181616
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value284221209192
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths1234.81227.81306.21200.0

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value36292224
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value362286265246
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive1005.6986.21204.51025.0

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value33262122
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value339268249232
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour1027.31030.81185.71054.5

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value31242120
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value319251235218
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree1029.01045.81119.01090.0

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value29211919
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-312018-12-312017-12-31
Value301235221206
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo1037.91119.01163.21084.2

us-gaap:DefinedBenefitPlanFairValueOfPlanAssets us-gaap:DefinedBenefitPlanByPlanAssetCategories, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanFairValueOfPlanAssets

abbv:DefinedBenefitPlanOtherAssets, us-gaap:FairValueInputsLevel1, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value250132
Percentage of DefinedBenefitPlanFairValueOfPlanAssets100.0100.0

abbv:DefinedBenefitPlanOtherAssets, us-gaap:FairValueInputsLevel12And3, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value252132
Percentage of DefinedBenefitPlanFairValueOfPlanAssets100.8100.0

abbv:DefinedBenefitPlanOtherAssets, us-gaap:FairValueInputsLevel2, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-31
Value2.0
Percentage of DefinedBenefitPlanFairValueOfPlanAssets0.8

us-gaap:CorporateDebtSecurities, us-gaap:FairValueInputsLevel1, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value178112
Percentage of DefinedBenefitPlanFairValueOfPlanAssets71.284.8

us-gaap:CorporateDebtSecurities, us-gaap:FairValueInputsLevel12And3, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value854372
Percentage of DefinedBenefitPlanFairValueOfPlanAssets341.6281.8

us-gaap:CorporateDebtSecurities, us-gaap:FairValueInputsLevel2, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value676260
Percentage of DefinedBenefitPlanFairValueOfPlanAssets270.4197.0

us-gaap:DefinedBenefitPlanEquitySecuritiesNonUs, us-gaap:FairValueInputsLevel1, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value524349
Percentage of DefinedBenefitPlanFairValueOfPlanAssets209.6264.4

us-gaap:DefinedBenefitPlanEquitySecuritiesNonUs, us-gaap:FairValueInputsLevel12And3, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value524349
Percentage of DefinedBenefitPlanFairValueOfPlanAssets209.6264.4

us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCap, us-gaap:FairValueInputsLevel1, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value1143884
Percentage of DefinedBenefitPlanFairValueOfPlanAssets457.2669.7

us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCap, us-gaap:FairValueInputsLevel12And3, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value1143884
Percentage of DefinedBenefitPlanFairValueOfPlanAssets457.2669.7

us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCap, us-gaap:FairValueInputsLevel1, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value164138
Percentage of DefinedBenefitPlanFairValueOfPlanAssets65.6104.5

us-gaap:DefinedBenefitPlanEquitySecuritiesUsMidCap, us-gaap:FairValueInputsLevel12And3, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value164138
Percentage of DefinedBenefitPlanFairValueOfPlanAssets65.6104.5

us-gaap:ForeignGovernmentDebtSecurities, us-gaap:FairValueInputsLevel1, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value39784
Percentage of DefinedBenefitPlanFairValueOfPlanAssets158.863.6

us-gaap:ForeignGovernmentDebtSecurities, us-gaap:FairValueInputsLevel12And3, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value544202
Percentage of DefinedBenefitPlanFairValueOfPlanAssets217.6153.0

us-gaap:ForeignGovernmentDebtSecurities, us-gaap:FairValueInputsLevel2, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value147118
Percentage of DefinedBenefitPlanFairValueOfPlanAssets58.889.4

us-gaap:MutualFund, us-gaap:FairValueInputsLevel12And3, us-gaap:PensionPlansDefinedBenefit


Defined
Period End2020-12-312019-12-31
Value310296
Percentage of DefinedBenefitPlanFairValueOfPlanAssets124.0224.2

us-gaap:MutualFund, us-gaap:FairValueInputsLevel2, us-gaap:PensionPlansDefinedBenefit